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                                                    ABSTRACT
  
  Abstract    
 
 
 
Pluripotency in the early mouse is established and maintained by a gene regulatory 
network under the control of a core set of transcription factors that includes Oct4, 
Sox2 and Nanog. This network is shared by the embryonic stem cells which can give 
rise to any adult cell type thanks in part to this network, which shuts down the cells´ 
differentiation programs and keeps them in an undifferentiated state. While the 
network is largely conserved in eutherian mammals, very little information is available 
regarding its evolutionary conservation in other vertebrates. We have compared the 
embryonic pluripotency networks in mouse and chick by means of expression analysis 
in the pre-gastrulation chick embryo, genomic comparisons, functional assays of 
pluripotency-related regulatory elements in ES cells and blastocysts, and in vivo 
overexpression assays. We find that multiple components of the network are either 
novel to mammals or have acquired novel expression domains in early developmental 
stages of the mouse. We also find that the downstream action of the mouse core 
pluripotency factors is largely mediated by genomic sequence elements that are not 
conserved with chick. In the case of Sox2 and Fgf4, we find that elements driving 
expression in embryonic pluripotent cells have evolved through a small number of 
nucleotide changes that created novel binding sites for core factors.  
These findings suggest that the EP-GRN arose not only through the appearance of 
novel pluripotency genes but also by co-opting and duplicating existing genes and 
establishing new regulatory interactions between them. The de novo appearance of 
some of these interactions in mammals was confirmed by overexpressing Nanog in 
chick and mouse embryos. Furthermore, expression analysis of these embryos 
suggests additional conserved roles for Nanog as a repressor of neural and 
haematopoietic differentiation at gastrulation stages. 
Our results show that the network in charge of embryonic pluripotency is an 
evolutionary novelty of mammals that may have evolved owing to the comparatively 
extended period during which mammalian embryonic cells need to be maintained in 
an undetermined state prior to differentiation. Further knowledge of how this 
embryonic pluripotency changed during evolution will provide a deeper understanding 
of its control and it will extend our ability to exploit the potential of stem cells.
 
  Resumen 
   
La pluripotencia en el embrión temprano de ratón la establece y mantiene una red 
génica regulatoria bajo el control de un grupo central de factores de transcripción que 
incluye Oct4, Sox2 y Nanog. Esta red la comparten las células madre embrionarias que 
pueden dar lugar a cualquier tipo de célula adulta gracias en parte a que esta red actúa 
bloqueando los programas celulares de diferenciación mientras mantiene a las células 
en un estado indiferenciado. Esta red está ampliamente conservada en mamíferos 
euterios pero poco se sabe de su conservación evolutiva en otros vertebrados. Hemos 
comparado las redes de pluripotencia embrionaria de ratón y pollo por medio de 
análisis de expresión del embrión de pollo pre-gastrulatorio, comparaciones 
genómicas, ensayos funcionales con los elementos reguladores relacionados con la 
pluripotencia en células madre y blastocistos, así como por ensayos de sobreexpresión 
in vivo. Hemos encontrado que múltiples componentes de la red son nuevos en 
mamíferos o han adquirido nuevos dominios de expresión en los estadios tempranos 
del desarrollo del ratón. También que la acción downstream de los factores centrales 
de pluripotencia en ratón, esta mediada por elementos de secuencia genómica que no 
están conservados en pollo. En el caso de Sox2 y Fgf4 encontramos que elementos que 
dirigen la expresión en las células embrionarias pluripotentes evolucionaron por un 
pequeño número de cambios en los nucleótidos que crearon nuevos sitios de unión 
para los factores centrales. Estos resultados sugieren que la red regulatoria génica de 
la pluripotencia embrionaria surgió no solo por la aparición de nuevos genes sino 
también por cooptación y duplicación de genes ya existentes y por la aparición de 
nuevas interacciones entre ellos. De hecho sobreexpresando Nanog en embriones de 
pollo y ratón confirmamos que algunas interacciones son nuevas en este último. Por 
otra parte, el análisis de expresión de estos embriones sugiere que Nanog tiene un 
papel adicional y conservado como represor de diferenciación neural y 
hematopoyética en estadíos gastrulatorios. Los resultados muestran que la red 
encargada de la pluripotencia embrionaria es una novedad evolutiva de mamíferos 
que surgió quizá porque éstos necesitaban de un mantenimiento del estado 
indeterminado de las células embrionarias mucho más prolongado que otros 
vertebrados. Un mayor conocimiento de cómo la pluripotencia embrionaria ha 
evolucionado nos ayudará a comprender en profundidad su control y a entender y usar 
todo el potencial de las células madre. 
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1. EARLY MOUSE DEVELOPMENT 
Embryonic development is the process by which all lineages and cell types that form an 
organism from a single cell are specified. For a short period during the embryonic 
development of mammals, a subset of cells retains the capacity to give rise to all 
embryonic lineages including the germline (Smith, 2005). This unique capacity, called 
pluripotency, is lost progressively as cells differentiate and is preserved only in the 
primordial germ lineage, the precursors of the gametes, which retain pluripotency 
through later development and into adulthood. Pluripotency is also exhibited by 
embryonic stem cells in culture. Pluripotency is established and maintained by a gene 
regulatory network in which a core set of transcription factors controls an extended 
network of other genes. Despite the importance of this network, little is known about 
how it arose during evolution. 
1.1 Pre-implantation development 
Over the first four days after fertilization, the mouse embryo passes through a series of 
stages before implanting in the lining of the uterus. These early embryonic stages in 
mammals are quite distinct from early stages in non-mammals, where embryos rely on 
the nutritional deposits carried in the egg. In mammals, embryo nourishment depends 
exclusively on the mother, so the embryo must implant in order to survive and grow. 
Therefore the early differentiation events that occur during this period are devoted to 
the formation of supporting structures to enable stable implantation and nutrition, 
and to the segregation of embryonic lineages.  
The fertilized egg divides symmetrically to give rise to an embryo of two cells and 
subsequent divisions form an embryo of four and eight cells (Fig. 1). Transition from 
maternal to zygotic transcripts begins during these first divisions and is known as the 
zygotic genome activation (ZGA) (Cockburn and Rossant, 2010). 
 After 2.5 days (E2.5), the embryo undergoes compaction and the cells acquire a 
polarized epithelial morphology that will be maintained in the outer cells during the 
subsequent divisions of 16 and 32 cells (late morula). The distinction between inner 
and outer cells gives rise at 3.5 days to the first lineage decision of the embryo: the 
Introduction 
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formation of the inner cell mass (ICM) and the surrounding trophectoderm (TE). At the 
same time fluid is pumped into the embryo and a cavity known as blastocoele is 
formed. With the formation of the blastocoele, the mouse embryo is now considered a 
blastocyst. Twenty four hours after the formation of this structure, in the second 
lineage decision, the ICM gives rise to the epiblast (EPI), which will generate the 
embryo proper, and the primitive endoderm (PE), that will generate an 
extraembryonic tissue, the yolk sac (Fig. 1). Other extraembryonic tissues that will 
mostly constitute the placenta will come from the TE. 
 
 
Figure 1. Stages of preimplantation mouse development from fertilization to the formation 
of the blastocyst. The fertilized egg undergoes three rounds of cleavage division to reach the 
eight cell stage. In the next stage, named the early morula, blastomeres undergo subsequent 
divisions and a process of compaction and polarization at 2.5 days. In the late morula this 
process generates differences between the inside and outside cells that later will give rise to 
the ICM and TE lineages respectively. The outer cells form the trophectodermal epithelium and 
pump fluid internally to form the blastocoele cavity at 3 days, which continues its expansion 
through the early blastocyst (E3.5) and late blastocyst (E4.5). In this late stage, the ICM 
segregates into two lineages, the epiblast (EPI) and the primitive endoderm (PE). Modified 
from (Yamanaka et al., 2006). 
  Introduction 
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1.2 Post-implantation development   
By day 4.5 of development the embryo has implanted in the maternal uterine wall 
through the polar trophoectoderm, which directly overlies the ICM (Fig. 2A). Later 
these cells proliferate and expand to form the extraembryonic ectoderm (ExE) and the 
ectoplacental cone (EPC). Trophectodermal cells away from the ICM form the mural 
trophoectoderm; these cells stop dividing but continue to endoreduplicate their DNA 
to differentiate into the trophoblast giant cells (Fig. 2B) (Rossant and Cross, 2001). 
Between days 4.5 and 6, cells in the epiblast proliferate to reach the distal pole of the 
blastocyst, aided by the formation of the ExE. This phenomenon reduces the size of the 
blastocoele cavity and results in the invagination of the primitive endoderm, which 
remains as a layer around the epiblast and the trophoectoderm (Fig. 2B). Later, 
primitive endoderm cells differentiate. Some PE cells form a single layer with the 
trophoblast giant cells, called the parietal endoderm, which will give rise to the yolk 
sac. In contrast, the primitive endoderm next to the epiblast and trophoblast forms the 
visceral endoderm. By 6.5 days the anteroposterior axis of the embryo is established 
when the anterior visceral endoderm migrates and the mesoderm is specified as the 
posterior region (Fig. 2C). This is the onset of gastrulation, a process that will lead to 
the formation of the three germ layers of the embryo: the ectoderm, mesoderm and 
definitive endoderm. 
 
 
 
 
 
 
 
 
 
Figure 2. Lineage descendants of the three lineages of the blastocyst up to the time of 
gastrulation (Rossant, 2004). 
B A C 
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1.3 Blastocyst derived stem cell 
The succession of cells from blastocyst to gastrula is in a transient state that is lost with 
the differentiation events that take place during development. However, this transient 
state can be “captured” by removing cells at different stages and culturing them in 
vitro. Thus in the early blastocyst, the ICM is the source of embryonic stem cells (ES) 
and trophectoderm the source of trophoblast stem cells (TS), whereas in the late 
blastocyst the epiblast is the source of epiblast stem cells (EpiS) and the primitive 
endoderm is the source of XEN cells. At later stages the primordial germ cells (PGCs), 
precursors of the gametes, are the source of embryonic germ cells (EG) (Fig. 3). 
All these cell types have the ability of self-renewal, which confers them with the 
capacity to proliferate indefinitely when cultured under defined conditions. 
Furthermore, they have the potential to differentiate into any cell type of the tissues 
for which they are precursors. Consequently cells derived from ICM, epiblast or 
primordial germ cells can give rise to all lineages of the embryo and are therefore 
considered pluripotent. Moreover, the derived cells in culture constitute a 
representative in vitro model for the study of the gene regulatory logic that controls 
animal embryonic development. 
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Figure 3. Embryonic pluripotent lineages as source of stem cells. In the early blastocyst, 
trophoblast (TS) and embryonic stem cells (ES) can be derived from TE and ICM, respectively. 
In the late blastocyst, the extraembryonic endoderm (primitive endoderm and its derivates) 
and epiblast are the sources of XEN cells and EpiS cells, respectively. At subsequent stages, the 
ability to derive these cells from the mouse embryo is progressively lost. The embryo starts 
gastrulation, which involves the formation of the three germ layers and the specification of the 
primordial germ cells (PGCs) in the epiblast from day 6.25; PGCs are the source of embryonic 
germ cells (EG). TE, trophoectoderm; ICM, inner cell mass; PE, primitive endoderm; EPI, 
epiblast; XEN, 
 
 endoderm cells; EPC, ectoplacental cone; ExE, extraembryonic ectoderm; PaE, 
parietal endoderm; VE, visceral endoderm; PEct, primitive ectoderm; MI, mesoderm 
invagination. Modified from (Boiani and Scholer, 2005; Yamanaka et al., 2006). 
2. GENETIC CONTROL OF BLASTOCYST LINEAGES 
2.1. Gene regulatory networks 
Underlying the control of animal development we find thousands of genes that are 
arranged in gene regulatory networks (GRNs) that specify the sets of genes that must 
be expressed in specific spatial and temporal patterns. This progressively generates 
developmental patterns and executes the construction of multiple states of 
differentiation. The control system consists of modular DNA sequences; each module 
is activated or repressed by regulatory proteins such as transcription factors (TFs). TFs 
recognize specific DNA sequences in associated genes, controlling their transcription.
Introduction 
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 Some regulatory proteins control the activities of genes encoding other regulatory 
proteins, and their functional linkages then define the core networks (Davidson and 
Levin, 2005). 
Current understanding of the GRNs underlying pre-implantation stages of mouse 
development is based mainly on studies with mutant mice and derived blastocyst cells. 
The results show that the segregation of lineages in mouse development is highly 
regulated by GRNs in which different transcription factors are expressed specifically in 
each cell type.  
2.2. ICM versus TE fate  
Several transcription factors are known to play key roles in determining the ICM and TE 
fates. Cdx2 is required for TE development, while Oct4 (official symbol Pou5f1), Nanog 
and Sox2 are involved in establishing the ICM. In the mouse, Cdx2 is first detected at 
the eight-cell stage and becomes restricted in the late morula to the outer cells, the 
future TE (Niwa et al., 2005). Oct4, Nanog and Sox2 are initially expressed in a 
stochastic fashion (Dietrich and Hiiragi, 2007) and only later become restricted to the 
inside cells, the future ICM cells. Reciprocal repression between Cdx2 and the Oct4-
Nanog-Sox2 axis reinforces the segregation of the ICM and TE fates, together with the 
autoregulation of Cdx2 and Oct4. As a result, upregulation of Cdx2 in the outside cells 
is followed by downregulation in the same cells of Oct4, Nanog and Sox2 (Fig. 4) 
(Cockburn and Rossant, 2010). 
Null mutants have been obtained for Cdx2 and Oct4, and both exhibit defects that 
correlate with their expression patterns. Cdx2 mutant embryos form blastocysts but 
the TE in these embryos loses its epithelial integrity because Oct4 and Nanog are 
ectopically expressed in outside cells at the blastocyst stage. Thus, the embryos cannot 
differentiate further, eventually leading to blastocyst death before implantation 
(Strumpf et al., 2005). Oct4 null embryos form a functional TE, and the blastocysts are 
able to implant; however, they die soon after because they lack ICM derivates such as 
the epiblast and yolk sac (Nichols et al., 1998). 
  Introduction 
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2.3. Epiblast versus primitive endoderm fate  
The second lineage decision, between epiblast and primitive endoderm, depends on 
the activity of the transcription factors Nanog and Gata4/6. The ICM is composed of 
two cell types arranged in a mosaic pattern: the presumptive PE cells express Gata6 
and Gata4 and the EPI cells express Nanog. Nanog is required for EPI determination 
and later signals from these Nanog expressing cells are essential for the formation of 
the PE (Fig. 4) (Messerschmidt and Kemler).  
Nanog-deficient embryos die before implantation; the Nanog-null ICM cells lose their 
differentiation potential and are only capable of TE differentiation or undergo 
apoptosis (Silva et al., 2009). Gata4/6 mutants show deficits in establishing PE and fail 
to maintain PE derivates (Soudais et al., 1995). 
 
Figure 4. Lineage decisions in the pre-
implantation mouse embryo. Mutually 
antagonistic Cdx2 and Oct4 drive the first 
lineage decision. In the second lineage 
decision, Nanog specifies EPI fate and 
promotes PE formation, possibly by a 
combination of paracrine signalling and 
cell-cell interaction. TP, totipotent 
precursor. Modified from (Messerschmidt 
and Kemler, 2010). 
 
2.4. Peri-implantation stages 
Axis formation and patterning, which occurs between 5.5 and 6.5 days, is driven by the 
expression and reciprocal interactions of other signalling molecules. These molecules 
are also necessary for the maintenance and proliferation of the trophoblast.   
Fgf4 and Nodal, which are first triggers of differentiation at these stages, are expressed 
in the epiblast, Fgf4 is directly downstream of Oct4 and Sox2 (Yuan et al., 1995). Fgf4 is 
widely expressed during early pre-implantation development, and then becomes 
confined to the ICM at the blastocyst stage and is eventually restricted to the early 
post-implantation epiblast. Fgf4 has a role in PE formation (Feldman et al., 1995) and 
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in the expression patterns of other FGF pathway components in the early embryo 
(Arman et al., 1998; Chai et al., 1998). Nodal, which is also found at early post-
implantation stages, promotes posterior cell fate in the epiblast and signaling to the 
visceral endoderm, all leading to the establishment of anterior-posterior polarity 
(Brennan et al., 2001).  
Both genes also have a role in the extraembryonic lineage through their inductive 
action on the extraembryonic ectoderm, contributing to the expression of Eomes, Cdx2 
and Esrrβ transcription factors and preventing precocious differentiation of the ExE 
into the ectoplacental cone (Fig. 5) (Niswander and Martin, 1992; Rappolee et al., 
1994). Eomes, which is downstream of Cdx2, is initially expressed in the TE at the 
blastocyst stage and is restricted to the ExE after implantation (Ciruna and Rossant, 
1999). Esrrβ transcripts are first detected in the ExE at E5.5 (Luo et al., 1997). 
 
Figure 5. Reciprocal inductive interactions 
between the ExE and EPI. Nodal is 
processed in the ExE by the convertases 
Spc1 and Spc4. Processed Nodal (Nodal-P) 
maintains the expression of Cdx2, Esrrβ 
and Eomes in the ExE and contributes to 
the establishment of the embryo axis in 
the EPI. Fgf4, together with its receptor in 
the ExE, Fgfr2, also contributes to the 
expression of Cdx2, Eomes and EsrrB, and 
represses expression of the differentiation 
promoter Ascl2, restricting it to the EPC. 
ECP, ectoplacental cone; ExE, 
Extraembryonic ectoderm; EPI, Epiblast. 
(Arman et al., 1998; Guzman-Ayala et al., 
2004) 
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3. PLURIPOTENCY 
3.1 ES cells and the embryonic pluripotency gene regulatory network (EP-GRN) 
ES cells possess many features that make them an attractive model for studying the 
molecular basis underlying embryonic development. ES cells are an invaluable tool for 
the study of mouse gene functions thanks to their ability to contribute to chimeras 
(Tam and Rossant, 2003), and can also be modified genetically or cultured under 
controlled conditions in vitro to monitor effects of the intra or extracellular 
environment.  
Studies in ES cells have begun to unravel the GRNs that govern embryonic 
pluripotency. Furthermore, it is easy to obtain enough material from ES cell culture to 
perform genome-wide DNA binding protein localization studies, such as chromatin 
immunoprecipitation followed by microarray (ChIP-chip) or by direct sequencing (ChIP-
seq) (Chen et al., 2008; Kim et al., 2008 ). These studies have increased our 
understanding of the molecular basis that controls pluripotency and have generated 
extensive datasets for further analysis.  
Research with mouse ES cells has shown that pluripotency in ES cells and in the 
blastocyst results from the expression of a small network of transcription factors 
whose core members are the products of the Oct4, Nanog and Sox2 genes (Fig. 6) 
(Silva and Smith, 2008). These genes actively maintain the undetermined state while 
also repressing the differentiation programme (Boiani and Scholer, 2005; Niwa, 2007). 
The core factors act together through auto- and cross-regulatory interactions and also 
through direct and overlapping binding to multiple locations throughout the genome, 
where they regulate downstream target genes (Fig. 7) (Boyer et al., 2005; Loh et al., 
2006; Marson et al., 2008). These transcription factors lie at the core of an extended 
GRN, which includes other transcription factors as well as epigenetic modifiers and 
signalling molecules. Their coordinated activity is ultimately responsible for the 
pluripotent state by controlling gene transcription in a combinatorial manner. In fact 
the differential regulation of the target genes is determined by the extent of regulatory 
element occupancy by diverse and multiple factors (Kim et al., 2008). 
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Figure 6. Pluripotency results from the action of a core set of transcription factors in the ICM 
cells and in ES cells. The core members of the network Oct4, Sox2 and Nanog control an 
extended network of genes. ES cells offer a frozen state in development, in which the GRN 
responsible for embryonic pluripotency (EP-GRN) is maintained indefinitely, and the activation 
of differentiation programmes can be controlled experimentally by culture conditions (Silva 
and Smith, 2008).  
 
 
 
 
 
 
 
 
 
 
Figure 7. The core pluripotency GRN in ES cells. Oct4, Sox2 and Nanog are central to the 
maintenance of the ES cell undetermined state. These genes co-occupy many target genes, 
activating other ES cell-specific genes while repressing the expression of genes associated with 
lineage commitment. The commitment to specific cell lineages results in changes in gene 
expression that include downregulation of the core transcription factors and the upregulation 
of differentiation genes. These three transcription factors regulate their own and each other’s 
expression in a highly coordinated manner. This is achieved through multiple positive protein-
protein and protein-DNA feedback interactions. For example, Oct4 and Sox2 form a 
heterodimer that positively regulates the expression of Oct4, Sox2 and Nanog (Boyer et al., 
2005; Loh et al., 2006). In the core network blue shapes denote genes and pink hexagons 
denote the corresponding proteins. Dotted arrows indicate potential feedback mechanisms 
from downstream targets, back to the core circuit. Modified from (Macarthur et al., 2009).
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Pluripotency is maintained through a complex interplay between the core network and 
peripheral signalling molecules. In the embryo these molecules are provided by the 
extracellular environment, whereas in ES cells extrinsic factors are added to the 
growth medium to create an appropriate external environment. For example, the 
cytokine leukemia inhibitory factor (LIF) and serum containing bone morphogenetic 
proteins (BMPs) are required to suppress differentiation and activate genes involved in 
self-renewal (Williams et al., 1988; Ying et al., 2003). Alternatively, a cocktail of 
enzyme inhibitors can be added to the medium to block differentiation signals 
generated autonomously by ES cells (Silva and Smith, 2008). 
The central role of the core factors in pluripotency became more evident with 
generation of induced pluripotent stem cells (iPs), first obtained in 2006 (Takahashi 
and Yamanaka, 2006). Since then it has been shown that a wide range of murine and 
human somatic cells can be reprogrammed back to pluripotent stem cells by 
exogenous expression of specific combinations of transcription factors. The specific 
factors needed for reprogramming depend on the type of somatic cells being 
reprogrammed. Nonetheless, these combinations always include Oct4 and Sox2, which 
are alone sufficient to initiate the reprogramming cascade (Takahashi and Yamanaka, 
2006). Depending on the cell type, Nanog and other factors are included, such as Klf-4, 
Lin28 or c-Myc (Judson et al., 2009; Takahashi and Yamanaka, 2006; Yu et al., 2007). 
After the introduction of the combination of transcription factors, the somatic cells 
reach the undifferentiated state by passing through a series of reprogramming events 
that include the demethylation and posterior activation of Oct4, Sox2 and Nanog, 
which will be consistently expressed in the iPs. 
ES cells share many features with EG cells, which are derived from primordial germ 
cells (PGCs) (Fig. 3). From about day 7.5 onwards, expression of the core factors Nanog 
and Oct4 becomes restricted to PGCs, where they play critical roles in germ cell 
specification and development (Chambers et al., 2007; Okamura et al., 2008). EG 
derived cells thus express the core pluripotency transcription factors, and despite their 
distinct origins are in a similar molecular ground state to ES cells (Leitch et al.). 
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3.2. Biochemical and functional properties of EP-GRN core factors  
The functional form of the Nanog protein is a homodimer. Dimerization requires a 
tryptophan repeat region located in the C-terminal half of the protein (Fig. 8A).  In 
culture, constitutive expression of mouse Nanog is able to maintain the ES 
pluripotency state in the absence of LIF (Chambers et al., 2003). This capacity is lost 
when the tryptophan repeat-region is deleted or mutated (Mullin et al., 2008; Wang et 
al., 2008) because Nanog dimerization is required for its ability to interact with other 
pluripotency proteins and therefore to promote self-renewal and repress 
differentiation (Fig. 8B) (Torres and Watt, 2008; Wang et al., 2008).  
Experiments in ES cells have shown the importance for pluripotency maintenance of a 
tight regulation of the core factors. Analysis of an Oct4-null mouse ES cell line, in which 
self-renewal is sustained by a tetracycline-suppressible Oct4 transgene, revealed that 
suppression of the transgene triggered differentiation into trophectoderm (Kunath et 
al., 2004). Surprisingly, when the same transgene was expressed in heterozygous ES 
cells (Oct4+/-), the additional amounts of Oct4 protein did not lead to better 
maintenance of pluripotency but caused differentiation (Niwa et al., 2000). In contrast 
to Oct4, Nanog deficiency does not commit ES cells to differentiation, and Nanog-null 
ES cells continue to self-renew even though they have an increased propensity to 
differentiate. Thus, while Nanog is indispensable for the formation of the ICM and 
germ cells, in ES cells it appears to act as a rheostat, conferring variable resistance to 
differentiation.  Nanog levels fluctuate and cells with reduced Nanog levels are more 
prone to differentiate. These low levels would be like a “window of opportunity”, in 
which intrinsic or environmental perturbations can be consolidated into a lineage 
commitment decision or may be overcome by re-expression of Nanog (Chambers et 
al., 2007; Kalmar et al., 2009). 
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Figure 8. A) Mouse Nanog protein domains. The N-terminal half of Nanog contains a serine-
rich motif in the N-terminal domain (ND) and a DNA-binding homedomain (HD). In the C-
terminal half, two C-terminal domains, CD1 and CD2, are separated by a dimerization domain 
(WR), in which every fifth residue is a tryptophan; mouse Nanog has 10 copies of this motif 
(Chambers and Tomlinson, 2009). B) Model showing the mechanism of action of Nanog in ES 
cells. Nanog inhibits the expression of NFκB-dependent genes required for differentiation and 
synergistically activates Stat3-dependent promoters, bypassing the requirement of LIF 
.Modified from (Torres and Watt, 2008). 
 
4. EP-GRNs IN NON-MAMMALIAN VERTEBRATES  
Certain features of early lineage determination in the mammalian blastocyst can be 
considered evolutionary novelties, in the sense that they do not appear in other 
vertebrates. For example, non-mammalian vertebrates have no homologue of the TE, 
and the placenta is clearly a mammalian innovation. This raises the question of the 
extent to which genetic control of these early phases of mammalian development, in 
particular the establishment and maintenance of embryonic pluripotency, is conserved 
in other vertebrates. 
Current knowledge is very much limited to the mouse, mainly due to the unique 
resource represented by ES cells. Little is known about the EP-GRNs present in other 
organisms, even though pluripotency is a necessary and transient stage in the 
development of any multicellular organism that passes through an obligatory one-cell 
stage as part of its life cycle.  A few very recent studies have examined the 
evolutionary conservation of EP-GRNs in ES cells and early embryos between three 
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mammalian species: human, mouse and cow (Kunarso et al., 2010; Xie et al., 2010). 
These studies show that the EP-GRN varies significantly between mammals, but this 
variation appears to occur mainly in peripheral components of the network. Although 
interesting, these comparisons provide little insight into how deeply the EP-GRN is 
conserved beyond mammals and how it appeared during evolution. 
Published reports in non-mammalian vertebrates are limited to the description and 
analysis of homologues of the core mammalian EP transcription factors Oct4 and 
Nanog. Oct4 homologues have been described in two species of fish. Early zebrafish 
express Pou2/spg and medaka embryos express Ol-Oct4. Ol-Oct4 is also expressed in 
adult gonads of medaka; however, this pattern is not seen for zebrafish pou2/spg 
(Burgess et al., 2002; Sanchez-Sanchez et al., 2010). A medaka homologue of Nanog 
has been identified and has been linked to proliferation during early embryo 
development (Camp et al., 2009). 
Three tandem duplicated Oct4 homologues have been isolated in the anuran 
amphibian Xenopus. One of them, Xlpou91, has the capacity to maintain pluripotency 
in murine Oct4 null ES cells, and thus shares functional similarity with mammalian Oct4 
(Morrison and Brickman, 2006). No homologues of mammalian Nanog have been 
found in Xenopus. In contrast, axolotl, a urodele amphibian, contains homologues of 
Oct4 and Nanog: Axoct-4 is expressed in the early embryo but not in the PGCs 
(Bachvarova et al., 2004), and AxNanog can sustain pluripotency in mouse ES cells 
(Dixon et al., 2010). In chick, the Oct4 and Nanog homologues also sustain mouse ES 
cell function in culture (Canon et al., 2006; Lavial et al., 2007). 
While these reports point to a functional conservation of these factors among 
vertebrates, some territories of early expression are not conserved in non-mammals 
(Canon et al., 2006) and the wiring of the network in non mammals is not known. 
Therefore we lack a clear understanding of the evolution of EP-GRN, and there is a 
need to compare the mouse EP-GRN with the regulation at equivalent stages in non-
mammals.
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4.1 The chick as a model  
Birds, like mammals are amniotes: they lack a larval stage and instead they have a 
terrestrially adapted egg protected by a specific arrangement of extraembryonic 
membranes.  
The chick (Gallus gallus) is an ideal model for making comparisons with mammals. The 
lineages of birds and mammals are separated by huge time gap of around 310 million 
years. This places them at a sufficient evolutionary distance for important differences 
to have arisen, while being sufficiently close to allow meaningful comparisons. In 
contrast, the early development of marsupials does not differ markedly from 
eutherians (Selwood and Johnson, 2006), and the other mammalian group (the 
monotremes) is not so easily available (Fig. 11).  
 
 
 
 
 
 
 
 
 
 
Figure 11. Relationships of the major mammalian groups with other vertebrates. The time 
scale is in millions of years (Myr). The ancestors of birds and mammals diverged around 310 
million years ago. Marsupials comprise a single taxonomic unit (Metatheria), traditionally 
considered the sister group of Eutheria from which they diverged 130 million years ago. Red 
lines represent groups from which whole genome sequence are available. Modified from 
(Graves and Westerman, 2002). 
Furthermore the recent sequencing of the chick genome (consortium, 2004) has 
confirmed the chick as a very valuable resource for comparative genomic analysis. 
Several characteristics make it especially useful for the identification of conserved non-
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coding regions: the mentioned evolutionary position filling a gap in the genomes 
sequenced so far; the compactness of its genome, 40% respect to human and mouse; 
and that the chick genome has not undergone any recent duplication like teleosts 
fishes or many anuran amphibians. Hence this last characteristic means that in most 
cases there is 1:1 correspondence between homologous genes in mammals and birds, 
which includes a high level of conservation in intronic and flanking non coding regions 
likely to contain important regulatory elements. In fact it is estimated that at least 70 
megabases (Mb) in the chick genome sequence are likely to encode functional, 
conserved elements, and there are long blocks of conserved synteny between chick 
and mammal genomes and a low rate of chromosome translocations (Stern, 2005). 
Moreover the chick embryo is a classical embryological model because of its ready 
availability. Methods for transient transgenesis are available and allow efficient 
alteration of gene function during early embryonic development. Electroporation, the 
most popular method of transient transfection, has allowed studies of gene gain or 
loss of function (Sauka-Spengler and Barembaum, 2008). What is more, blastoderm-
derived cells can now be derived in vitro from pre-primitive streak stages under 
specific culture conditions. These cells have been claimed to be the chick equivalent of 
mouse ES cells and might open the way to understanding the control of pluripotency in 
non-mammalian species (Petitte et al., 2004). 
4.2 Chick pre-gastrulation development 
Fertilization in the chick occurs during the time between release of the oocyte and its 
entry into the oviduct. Peristaltic movements carry the fertilized egg down the oviduct, 
a journey that takes about 20-23 h and during which the egg becomes surrounded by 
albumen (egg white), egg membranes and the shell.  
Early embryonic development also occurs during this time: in the hen’s oviduct the 
fertilized cell on top of the yolk undergoes cleavage divisions that result in the 
formation of a disc of cells called the blastodisc or blastoderm (Fig. 12) (Fig. 13 A, B). 
Between 12 and 14 hours after fertilization, the anterior-posterior axis is specified by 
gravitation.
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The early embryonic development is arbitrarily divided into 14 stages, numbered in 
Roman numerals (stages I to XIV) according to Eyal-Giladi & Kochav (EGK) (Eyal-Giladi 
and Kochav, 1976). The blastodisc or blastoderm corresponds to stage EGK-X, which is 
already composed of 20000-50000 cells, called blastodermal cells. Zygotic genome 
activation occurs at this stage (Zagris et al., 1998).  
By the time the egg is laid (EGK IX-X) the embryo can be divided morphologically into a 
darker area called the area opaca (AO), which is the peripheral part and attached to 
the yolk, and a more translucent area called the area pellucida (AP), in the central part 
of the embryo overlaying the subgerminal space, (Fig. 13C). The AO gives rise to 
extraembryonic structures, while the entire embryo and some of the extraembryonic 
tissues develop from the AP. Some AP cells delaminate to establish a layer of cells 
overlaying the yolk beneath the epiblast in the AP. This layer, called the hypoblast, 
gives rise to the extraembryonic endoderm. Hypoblast cells derive from two sources: 
the ingression of cells from the epiblast and the posterior marginal zone, a band of 
epithelial cells at the posterior lateral boundary between the AO and AP (Fig. 13D). 
Later the epiblast cells undergo a number of morphogenetic movements that enable 
the onset of gastrulation with the establishment of the primitive streak, the future axis 
of the embryo (Fig. 13E).  
Embryonic development after laying is arbitrarily divided into 46 stages denoted with 
Arabic numerals (stages 1-46) according to Hamburger and Hamilton (HH) (Hamburger 
and Hamilton, 1992), where HH stages 1-3 align with EGK stages XII- XIV. 
Figure 12. Fertilized hen’s egg when laid.  
The fertilized egg is confined to a small 
patch, several millimetres in diameter, 
lying on a large mass of yolk. Cell cleavage 
in the oviduct results in the formation of a 
disc of cells called the blastodisc or 
blastoderm Modified from (Wolpert, 
2002). 
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Figure 13. Pre-gastrulation 
development in the chick 
embryo. A) Before the egg is 
laid early cleavage furrows 
extend downward from the 
surface of the cytoplasm, but 
the cleavage is incomplete and 
initially does not separate the 
blastoderm from the yolk. B) 
Later cleavage results in a 
circular blastoderm several 
cells thick. C) The thinner 
central area, which overlays 
the subgerminal space, is 
known as the area pellucida, 
whereas the thicker marginal 
region is the area opaca. D) In 
the cavity a layer of cells 
develops over the yolk, called 
the hypoblast. This gives rise to 
the extraembryonic endoderm, 
while the epiblast will give rise 
to the embryo proper. E) The 
primitive streak starts to form 
and gradually extends further 
anteriorly. The primitive streak 
appears as a dark double line 
where a large number of 
epiblast mesenchymal cells 
have piled up, waiting to 
ingress (Wolpert, 2002). 
 
4.3 Chick orthologues of mouse early specification genes 
Unlike the mouse, where Nanog expression is found in the epiblast and thereafter 
becomes restricted to PGCs (Yamaguchi et al., 2005), the chick orthologue is not 
expressed in the whole epiblast at early stages but is restricted to individual PGCs 
scattered over the epiblast (Canon et al., 2006).  
Similarly to the situation in mouse, an Oct4-related gene is ubiquitously expressed in 
pre-gastrulation stages in both AO and AP and later becomes restricted to the epiblast 
when the primitive streak starts to form. At later stages its expression appears in the 
PGCs, a feature also shared with its murine counterpart (Lavial et al., 2007). 
A 
B 
C 
D 
E 
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Cdx2 and Eomes, which are critical for the specification and development of the 
trophectoderm in mouse, are expressed in the chick embryo in the AO at pre-
gastrulation stages, similarly to their expression in the TE of the mouse blastocyst. 
However, these genes are expressed in the reverse order to that seen in mouse TE 
(where Eomes is expressed downstream of Cdx2). Unexpectedly, chick Eomes is also 
present in a novel domain, the PGCs, which does not occur in mouse (Pernaute et al., 
2010). The Fgfr2 orthologue is not expressed at pre-gastrulation stages in chick 
(Pernaute et al., 2010), while in mouse it is expressed in the TE and its derivative, the 
extraembryonic ectoderm (Rossant and Cross, 2001). 
4.4 Comparing chick and mouse pre-gastrulation stages  
There are several key differences between early mouse and chick development before 
gastrulation. The most obvious is the existence of a nutritive yolk that feeds the 
embryo, a structure absent from mammalian embryos, where nourishment must be 
obtained through the TE-derived placenta. However, like the mouse, one of the 
earliest events to take place in the chick embryo is the separation of extraembryonic 
and embryonic territories. This segregation occurs shortly before laying (EGK-IX-X) with 
the distinction of the AO and AP. Soon after, the primary hypoblast arises from 
delamination of cells from the AP. This arrangement is topologically similar to that in 
mouse, with first the separation of extraembryonic and embryonic lineages and the 
subsequent formation of the primitive endoderm (Fig. 13) (O'Farrell et al., 2004).  
A particularly interesting stage for comparison with mouse embryos would be the pre-
streak stage (EGK X-XIII), when the hypoblast has already delaminated from the 
epiblast but gastrulation has not yet begun. This stage has been proposed to align 
more precisely than any other with the late mouse blastocyst (4.5-5.5 days) (Fig. 13). 
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Figure 13. Alignment of early embryonic stages between mammals and birds. In mammals, 
cells of the epiblast in the late blastocyst (blue) will begin gastrulation into the space between 
the epiblast and the primitive endoderm (yellow); in birds, at EGK-XII cells from the epiblast 
(blue) will likewise ingress into the space between the epiblast and the hypoblast (yellow). The 
cavity in which birds gastrulate can therefore be considered equivalent to the cavity in which 
mammals gastrulate. In birds this cavity is called the blastocoele, whereas in mammals the 
blastocoele is the cavity beneath the primitive endoderm, this cavity should be viewed as an 
empty yolk vesicle instead. Thus the traditional (and incorrect) nomenclature came about from 
the incorrect alignment of the early mammalian blastocyst (top left) with the chick EGK-XII-XIV 
(bottom right). Additional parallels can be found between mammals and birds in the formation 
of the yolk sac from primitive endoderm and hypoblast cells (yellow), respectively. Modified 
from (O'Farrell et al., 2004). 
 
The chick is thus an ideal model for comparing with mouse: not only can we make 
genomic comparisons and conduct functional assays; we can also make meaningful 
comparative expression analyses. Such a comparison can thus reveal whether the 
genetic control of embryonic pluripotency is a conserved feature of mammals and 
avians or, on the contrary, is a mammalian novelty.  
 
 
 
  
 
 
 
 
 
 
                                                 OBJECTIVES 
 
  Objectives 
 
26 
 
1. Explore the evolutionary history of Oct4 in vertebrates 
Before studying the conservation between mouse and chick embryonic pluripotency 
networks (objectives 2, 3, 4, 5), we aimed to clarify by phylogenetic, synteny and 
orthology analysis, the relationships of Oct4 with its homologues in other vertebrates.  
2. Compare the expression of the chick orthologues of mouse EP-GRN core factors 
and downstream targets  
We set out to analyse these genes by in situ hybridization at chick pre-gastrulation 
stages. This analysis was then extended by comparing the global expression profiles 
obtained by microarrays of early chick embryos and their derived cells with published 
data on the mouse pluripotent state. 
3. Search for the presence of chick orthologues of other mouse genes downstream of 
the core factors or of genes considered markers of pluripotency 
We searched for these chick orthologues by means of synteny analysis. 
4. Analyse the conservation between mouse and chick of the regulatory targets of 
the core EP transcription factors 
We aimed to study, by multi-species genomic alignments, the overall evolutionary 
conservation of non-coding regions bound in mouse ES cells by the core EP factors. To 
refine our analysis, we investigated the conservation of selected core EP factor binding 
sites in functional assays in ES cells and blastocysts. 
5. Analyse the conservation of Nanog function and its network during evolution 
After studying the overall conservation of the embryonic pluripotency network, we 
focused on one of the core factors, Nanog. We aimed to study the functional 
equivalence of Nanog orthologues in ES cells and to compare Nanog interactions 
between mouse and chick by overexpressing this gene in early embryos.  
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1. Animals models 
1.1 Chick  
Fertilized eggs were obtained from poultry farm Gibert, Tarragona, and incubated at 
38°C 100% humidity for a variable period in relation to the stage of interest. Pre-
gastrulation embryos were staged according to the Eyal-Giladi and Kochav (EGK series) 
(Eyal-Giladi and Kochav, 1976) and post-gastrulation were staged according to the 
Hamburger and Hamilton (HH series) (Hamburger and Hamilton, 1992). 
1.2 Mouse  
Double transgenic Nanog overexpressing line (Tg.TetOP-Nanog; ROSA26::rtTA) (Fig 1) 
was a kind gift from Dr. M. Serrano (CNIO, Madrid, Spain) and was generated by Dr K. 
Hochedlinger (Harvard University, Boston, USA) using the same strategy described for 
transgenic mice that ectopically overexpress Oct4 (Hochedlinger et al., 2005). The M2 
reverse tetracycline transactivator requires doxycycline for binding to the tetracycline 
operator (TetOP) consequently activating a CMV minimal promoter and thus, the over-
expression of Nanog (Fig 1).  
 
 
 
Figure 1. Schematic representation of transgenes used to produce Nanog-inducible mice. The 
M2 reverse tetracycline transactivator (M2-rtTA) was targeted to the ROSA26 locus for 
constitutive expression (M2-rtTA) under the control of ROSA26 promoter. A cassette 
containing Nanog cDNA and the tetracycline/doxycycline-responsive element (TetOP) with a 
CMV minimal promoter was targeted downstream of the collagen type 1 alpha 1 locus 
(Col1A1) by frt/Flpase-mediated site-specific integration. SA, splice acceptor; pA, 
polyadenylation signal. Black flags indicate transcriptional start sites. Modified from 
(Hochedlinger et al., 2005). 
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Nanog overexpression was induced by adding 0.2 mg/ml doxycycline in the drinking 
water given to pregnant females during the three days immediately before embryo 
extraction. Mouse embryos were staged according to Kaufmann (Kaufmann, 1992).  
For genotyping, the Tg.TetOP-Nanog transgenic allele was detected with a specific 
primer, col/frtC1 and a common primer, col/frt-B. The wild type (WT) allele was 
detected with a specific primer, col/frtA1 and the common primer. The PCR product 
for the transgenic allele was 551bp in length while for the WT allele was only 331bp. 
The ROSA26::rtTA transgenic allele was detected with a specific primer, B and a 
common primer, A. WT allele (+) was detected with specific primer, C and the common 
primer. The PCR product for the transgenic allele was 300bp in length while for the WT 
was 500bp (Table 1).  
 
Transgene Primer name Sequence Allele 
detected 
 
Tg.TetOP-Nanog  
 
col/frt-B 5'CCCTCCATGTGTGACCAAGG 3´ WT, 
Transgenic 
col/frtA1 5'GCA CAGCAT TGC GGA CATGC 3´ WT 
col/frtC1 5'GCAGAAGCGCGGCCGTCTGG 3´ Transgenic 
 
ROSA26::rtTA  
A 5'AAAGTCGCTCTGAGTTGTTAT 3´ WT, 
Transgenic 
B 5'GCGAAGAGTTTGTCCTCAACC 3´ Transgenic 
C 5'GGAGCGGGAGAAATGGATATG 3´ WT 
 
Table 1. Primers used for Nanog inducible mice line genotyping. Tg.TetOP-Nanog, 
tetracycline operator and Nanog cDNA inserted into the 3’ UTR of the Col1a1 locus; 
ROSA26::rtTA, reverse tetracycline transactivator (M2-rtTA) downstream of the ROSA26 
promoter. 
The transgenic line was maintained as double heterozygous breeding pairs (Tg.TetOP-
Nanog / +) (ROSA26::rtTA/+). Heterozygous males were mated with heterozygous or 
wild type females. The breed could be Nanog overexpressing embryos (named Nanog) 
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which had both transgenic alleles (Tg.TetOP-Nanog /+) (ROSA26::rtTA/+) or non 
overexpressing embryos (named controls) with three possible genotypes: (+/+) 
(ROSA26::rtTA/+), (Tg.TetOP-Nanog /+) (+/+) or (+/+), (+/+).  We grouped these three 
control genotypes as we did not observe differences between them. 
2. In situ hybridization 
Whole mount in situ hybridizations of chick and mouse embryos were carried out as 
described (Acloque et al., 2008; Ariza-McNaughton and Krumlauf, 2002). For early 
chick embryos (EGK-X), an average of 10 embryos was processed in parallel with later 
stages. This was important to confirm the reported gene expression patterns at later 
stages and to ensure that early embryos were developed for the appropriate time. 
Sense probes were used as negative controls. For chick and mouse Nanog 
overexpressing embryos, controls were processed in parallel for the same amount of 
time. Sources of probes used are described in Table 2. After in situ hybridization, 
selected chick embryos were embedded in paraffin and 0.7 micron sections were cut 
on a microtome. 
3. Inmunohistochemistry  
A monoclonal antibody raised in rabbit against the chick Vasa homolog protein 
(Tsunekawa et al., 2000) was kindly provided by Dr. Toshiaki Noce (Mitsubishi-Kasei 
Institute, Tokyo, Japan). After fixing in 4% paraformaldehyde in PBS and dehydrating in 
100% methanol, chick embryos were rehydrated in PBS containing 0.1% Tween-20. 
Embryos were then blocked for one hour in blocking solution (50mg blocking reagent 
(Roche), 100mM Maleic Acid, 150mM NaCl, 400ml water adjusted with NaOH at ph 
7.5) diluted 1:100 in B1 solution (100mM TrisCl ph 7.5, 150mM NaCl, 0.1% Triton X 
100). Primary antibodies were added in fresh 1% blocking solution at the following 
diultions: anti-Vasa, 1000 fold; mouse anti-GFP (JL-8 Clontech), 125 fold dilution. The 
embryos were incubated in this solution overnight at 4°C. After six 1 hour washes with 
B1 solution secondary antibodies were added and the embryos were incubated 
overnight at 4°C. Secondary antibodies were anti-rabbit Alexa 568 (A11011, Invitrogen) 
and anti-mouse Alexa 488 (A11029, Invitrogen). After five 1 hour washes in B1 
solution, embryos were examined under the fluorescence microscope. 
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Gene 
Name 
Species Source 
Oct4 M.musculus Dr. T. Rodríguez (MRC, London, UK) 
Pou2-r G.gallus PCR, Primers: F-Pou2, CATGTGCAAGCTGAAGCCACTGCT 
R-Pou2, TCAGTGGCTGCTGTTGTTCATGGAG 
Fgf4 G.gallus Dr. P. Bovolenta (Instituto Cajal, Madrid, Spain) 
Nodal G.gallus Dr. P. Bovolenta (Instituto Cajal, Madrid) 
Sox2 M.musculus Dr. T. Rodríguez (MRC, London, UK) 
Sox2 G.gallus MCR Geneservices (Boardman et al., 2002), clone ChEST878b12, 
acc. nº BU282995,   
FoxD3 G.gallus MCR Geneservices (Boardman et al., 2002), clone ChEST68l3, acc. 
nº BU128393,  
Phc1 G.gallus MCR Geneservices (Boardman et al., 2002), clone ChEST49d22, 
acc. nº BU219008,  
Sox3 G.gallus Dr. H. Kondoh (Graduate school of Frontier biosciences, Osaka, 
Japan) 
Sox1 G.gallus Dr. H. Kondoh (Graduate school of Frontier biosciences, Osaka, 
Japan) 
Eomes M.musculus Dr. T. Rodríguez (MRC, London, UK) 
Eomes G.gallus (Pernaute et al., 2010) 
Cdx2 M.musculus Dr. T. Rodríguez (MRC, London, UK) 
Cdx2 G.gallus (Pernaute et al., 2010) 
Fgf8 M.musculus Dr. J.J Sanz-Ezquerro (CNIC, Madrid, Spain) 
Fgf8 G.gallus Dr. M. Ros (IBBTEC, Santander, Spain) 
 
Table 2. Probes used for mouse (Mus musculus) and chick (Gallus gallus) in situ 
hybridizations
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4. Microarrays 
4.1 Sample preparation 
For chick microarrays 20 HH6 or 30 EGK-X stage embryos were dissected for each of 
three independent replicates. Blastoderm-derived cells (bdC) were isolated as 
described (Petitte et al., 2004). Briefly, 20 intact stage EGK-X area pellucidas for each 
of three independent replicates were placed into tubes containing PBS and 2% chick 
serum. After centrifugation PBS was replaced with trypsin 0.05% and incubated for 5 
min at room temperature. Dispersed cells were plated into 35 mm tissue culture 
dishes and cultured for 48 hr in DMEM containing 10% FBS, 2% chick serum, 100U/ml 
penicillin, 100ug/ml streptomycin and LIF. The cultured cells were positive for alkaline-
phosphatase (Fig 2) and showed high levels of expression, as determined by qPCR, of 
Pou2-r and Nanog as previously described (Lavial et al., 2007; Pain et al., 1996)  but 
undetectable levels of Sox2 in agreement with our whole mount in situ analysis (not 
shown). RNA was extracted from the cells using the RNeasy kit (Qiagen). Integrity and 
concentration of purified total RNA was determined by a 2100 Bioanalyzer (Agilent) 
and Nanodrop measurement (Agilent, ND-1000 spectrophotometer). 
Figure 2. Alkaline phosphastase 
staining in 2-day cultures of (A) mouse 
fibroblasts (negative control), (B) 
mouse ES cell colonies (positive 
control) and (C) chick blastoderm-
derived cells. 
 
For mouse microarrays, stage 9.5 mouse embryos were extracted and stored 
individually at -80°C until processed. Embryos were genotyped using the yolk sac, 
which was set aside during extraction. RNA was extracted from a pool of three Nanog 
overexpressing (Nanog) or non overexpressing embryos (controls) using the RNeasy kit 
(Qiagen). In total we obtained four replicates (of 3 embryos each) for each condition. 
Half of the replicates were pools of female embryos and the other half males, in case 
further analysis related with the sex was required. 
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4.2 Microarray analysis 
For chick microarrays, RNA was amplified and hybridized to the chick (V2) 4x44K Gene 
Expression Microarray (G2519F, Agilent Technologies) and for mouse, to the mouse 
whole genome 4x44K Gene Expression Microarray (G4122F, Agilent Technologies); 
scanning and image analysis was performed following the manufacturer's instructions. 
Preprocessing and statistical analysis of data was carried out at the CNIC Genomics 
Unit following standard procedures (Bolstad et al., 2003; Smyth, 2004).  
4.3 Data processing 
For chick microarrays three way comparisons of the expression data were performed 
with cut-offs of corrected p-value < 0.01 and -2>logFC>2 (log fold change) to identify 
those genes overrepresented in one sample versus the other. Sets of mouse genes that 
respond to downregulation of Oct4, Sox2 or Nanog by RNAi or overexpression of 
Nanog in ES cells were obtained from Sharov et al (Sharov et al., 2008). Genes 
downregulated in response to RNAi or upregulated in the case of Nanog 
overexpression were considered as activated by the core pluripotency factors, and as 
such a signature of the embryonic pluripotent stage. Genes upregulated in response to 
RNAi or downregulated in the case of Nanog overexpression were considered as 
repressed by the core pluripotency factors, and as such a set of genes that should not 
be overexpressed in the embryonic pluripotent stage. The percentage of the 
orthologues of over-represented chick genes in each sample (HH6, EGK-X, bdC) present 
in each mouse set was calculated independently for each EP factor and jointly for all 
factors, obtaining similar results (Table 3). The sets of genes involved in different 
aspects of pluripotency were obtained from (Tang et al., 2010) and analysed as 
described above (Table 4). 
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 Oct4 Sox2 Nanog Core EP-TF Total 
 up down up down up down up down  
HH6 213 156 131 234 76 155 303 354 1853 
EGK-X 239 189 153 240 71 156 337 376 2089 
bdC 153 238 87 303 84 192 245 438 1826 
Total 3617 2580 2035 3277 902 1802 4991 5314  
 
Table 3. Genes overexpressed in chick HH6 and EGK-X embryos, and blastoderm-derived cells 
(bdC), whose mouse orthologues are up or downregulated in response to interfering with the 
endogenous expression of the core EP transcription factors Oct4, Sox2 and Nanog (Sharov et 
al., 2008). 
 
 HH6 EGK-X bdC Total 
pluripotent genes 99 100 77 1408 
ES specific 317 249 197 2488 
ICM specific 236 221 231 2405 
represors of pluripotency 57 61 89 703 
self-renewal 27 16 12 229 
maintainence pluriotency 36 44 28 642 
Total 1853 2089 1826  
 
Table 4. Genes overexpressed in chick HH6 and EGK-X embryos, and blastoderm-derived cells 
(bdC), whose mouse orthologues are included in sets of genes defined in relation to embryonic 
pluripotency (Tang et al., 2010). 
 
For mouse microarrays, a corrected p-value cut-off of 0.05 was set to identify genes 
whose expression was significantly differentially regulated in the Nanog 
overexpressing mouse embryos. Based on the log FC, genes were sorted into Nanog 
upregulated (positive logFC) or Nanog downregulated (negative logFC). The top 
networks and canonical pathways were generated by Ingenuity pathway analysis 
(Ingenuity® Systems, www.ingenuity.com). A dataset containing gene identifiers and 
corresponding expression values was uploaded into the application. Each identifier 
was mapped to its corresponding object in Ingenuity's Knowledge Base. Network 
Eligible molecules (those with corrected p-value cutoff of 0.05), were overlaid onto a 
global molecular network developed from information contained in Ingenuity’s 
Knowledge Base. Networks of Network Eligible Molecules were then algorithmically 
generated based on their connectivity (Results Fig. 27). 
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5. Sequence analysis 
Chromosomal positions and genomic organization of chick and other vertebrate genes 
and genomic sequences from the Fgf4 and Sox2 locus were obtained from the latest 
release of the Ensembl genome browser (www.ensembl.org). 
Synteny analysis was aided by the use of the Genomicus browser, developed by the 
Dyogen Lab in Paris (www.dyogen.ens.fr) (Results Fig. 2, 10). Orthology maps were 
constructed by examining the presence of 1-to-1 orthologues in different species 
(opossum, chick, Xenopus and zebrafish) of all genes in a 10 Mb region surrounding 
mouse Oct4 and Nanog. Mouse genes with no orthologues in the species examined 
were not used, and when multiple matches to mouse genes were found in other 
species these were reduced to only one (Results Fig. 3). For phylogenetic analysis, 
sequences were aligned using Clustal X (Thompson et al., 1997) and edited using the 
BioEdit tool (Hall, 1999). The alignment was used to construct an unrooted neighbour-
joining bootstrapped tree (Felsenstein, 1996; Saitou and Nei, 1987) and drawn with 
Treeview (Page, 1996) (Results Fig. 4). 
Multi-species genomic alignments were performed using Vista tools (Frazer et al., 
2004). Sequences surrounding the Sox2/Oct4 sites and the multi-specie Nanog 
predicted proteins were aligned using Clustal X (Thompson et al., 1997), and edited 
with BioEdit (Hall, 1999). 
Genomic regions bound by Oct4 and Nanog in mouse ES cells were obtained from the 
ChIPseq data of (Marson et al., 2008). We included in the analysis regions bound 
together by four (Oct4, Nanog, Sox2 and Tcf3; 814 regions), three (Oct4, Nanog and 
Sox2; 638 regions) or two (Nanog and Oct4; 236 regions) core EP-GRN transcription 
factors, located at 8 kb or less from known genes. We obtained similar results if each 
of these subsets were analysed independently. Genomic regions bound by Gli3 in the 
mouse limb were obtained from the ChIP-seq data from (Vokes et al., 2008). For our 
analysis we used the 200 top-scoring regions as described in that paper. The 
coordinates for both data sets were converted from the mouse mm8 (February 2006) 
to the mm7 (August 2005) assembly and visualized using the Vista Tracks in the UCSC 
Browser (Frazer et al., 2004). These data sets were compared with rat, human, dog and 
chick. Each genomic region was individually analysed: a region was scored as 
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conserved if it contained at least one >100 bp segment showing over 70% similarity in 
intergenic, intronic or non-translated regions. Conserved regions overlapping coding 
exons were not included. Regions were scored as mammalian specific if they were 
conserved between mouse and at least one of the two non rodent species analysed 
(human and dog) (Results Fig 11A, B). A list of Ensemble transcript identifiers of those 
genes mapping in the vicinity (8kb or less) of the Oct4-Nanog bound regions (Marson 
et al., 2008)  was used to extract  from BioMart (www.biomart.org) the number of 
chick orthologues in the Oct4-Nanog data set (Results Fig. 11C). 
6. Constructs 
6.1 Reporter constructs 
Genomic fragments corresponding to the enhancers from mouse Sox2 and Fgf4 and 
the equivalent chick regions were amplified by PCR using the following BAC templates 
(http://bacpac.chori.org/) and primers: mouse Sox2, BAC RP24-140C7, 
AAGGCACCAAGAACCAGAAAT and TCAGCAAGTCCTCTCTGGGTA; mouse Fgf4, BAC 
RP23-294B14, GGTGAAAATATGCACGACCAG and TGAATGCTTCTCTTTGGATGG; chick 
Sox2, BACs CH261-178A15 and CH261-110M, AGATTCAGGCATTTGATCTCG and 
AAACAAGCGGTGAATTCCTCT. Chick Fgf4 was amplified from genomic DNA with 
ATGGTGTGAAAAGTGGCAAAG and TTTGGTGCAGTATTTGGAAGG. The fragments were 
cloned in pGem-T Easy vector (Promega) and mutated versions were generated by 
site-directed mutagenesis (Mutagenex Inc., NJ USA) (Table 5). 
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Name Wild type  Mutated version Changes 
Mouse-to-chick Fgf4 CTTTGTTTGGATGCTAAT aTTTGTTctatTGg-AAT 6 substitutions 
and 1 deletion 
Chick-to-mouse Fgf4 ATTTGTTCTATTGG-AAT cTTTGTTtggaTGctAAT 6 substitutions 
and 1 insertion 
Mouse-to-chick Sox2 CATTGTGATGCATAT tggTGTaAaGaAacc 9 substitutions 
Chick-to-mouse Sox2 TGGTGTAAAGAAACC catTGTgAtGcAtat 9 substitutions 
 
Table 5. Mutated versions of mouse and chick Fgf4 and Sox2 enhancers. The changes 
introduced are indicated in red and lower case. 
 
Wild type and mutated enhancer fragments were then cloned into a vector containing 
a human minimal beta-globin promoter upstream of a lacZ reporter linked to a SV40 
polyadenylation signal (Yee and Rigby, 1993) (This vector was a kind gift of Dr. R. 
Krumlauf; Stowers Institute, Kansas, USA.). This minimal beta-globin promoter is barely 
active, and needs of an enhancer, cloned upstream or downstream, to drive the 
expression of the lacZ reporter. Thus reporter activity provides a readout of the 
regulatory potential of the enhancer fragment.  
These constructs were used for both ES cell transfections and, once linearized and the 
plasmid backbone removed, for the generation of transgenic embryos. As a positive 
control we used the previously described Oct4 distal enhancer element (Oct4-DE) 
(Yeom et al., 1996) that was cloned following the same strategy, using BAC RP23-
152G18 as template and primers AGCGGCCGCCTCTGCTACATGTAAATTTGTCT and 
AGCGGCCGCCTAAACAAGTACTCAACCCTTGAA. 
6.2 Expression constructs  
A partial chick Nanog cDNA had been previously cloned in our group and used for in 
situ hybridizations (Canon et al., 2006). For further analysis in ES cells and for
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electroporation of chick embryos we needed the full-length sequence. We therefore 
obtained cDNA from total RNA from whole chick embryos at stage HH20 (Hamburger 
and Hamilton, 1992). Primers were designed using the predicted sequence (Table 6). 
For PCR a high fidelity polymerase, Platinum Taq (Invitrogen), was used and the 
amplification product cloned first into pGEM-T easy vector (Promega) and later into 
pPyCAGIP vector for stable transfections. This vector, a kind gift of Dr. I. Chambers 
(CMR, Edinburgh, UK), contains a CAG promoter (a combination of chick beta-actin 
promoter and cytomegalovirus immediate-early enhancer) followed by a stuffer. The 
cDNA is cloned in place of the stuffer fragment within a transcription unit linked to a 
puromycin resistance gene through IRES. The puromycin resistance gene allows 
elimination of untransfected ES cells (Chambers et al., 2003). 
Opossum Nanog was predicted in the opossum (Monodelphis domestica) genome 
annotation at reference ID ENSMODG00000017979 on chromosome 8, Ensembl vs49 
2008. To obtain the full-length opossum Nanog cDNA, we reverse transcribed RNA 
from stage Mc (McCrady) 29 genital ridges (Mate et al., 1994), a kind gift from Dr. K. 
Smith (Duke University, Durham, USA). A GeneRacer TM technique (Invitrogen) was 
used to amplify the 5’ and 3´ ends with primers designed from ``in silico´´ prediction 
using GenScan00000034861 (Table 6). Subsequently, primers were designed from the 
sequence obtained by GeneRacer TM and used to isolate full length Nanog sequence 
(Table 6). All PCRs were performed using Platinum Taq polymerase (Invitrogen) and the 
full length sequence was cloned initially into pGEM-T easy (Promega) and later into 
pPyCAGIP. Mouse Nanog cDNA was a kind gift of Dr I. Chambers (CRM, Edinburgh,UK) 
and was also cloned into pPyCAGIP. 
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For  Primer name Sequence 
Full-length Gg- Nanog F-fullGg 5´GCTCACCGCCAGCAACGGC 3´ 
R-fullGg 5´GGATCTATGAGTCAAGACCCTAG 3´ 
5´ end Md-Nanog F-GSPMd 5´CTGGTTGCTCCATACTGGAAGAGT 3´ 
R-GSPnestedMd 5´CGGATCTGCTGTGGGCTTAGGTAT 3´ 
3´ end Md-Nanog F-GSP-Md 5´CCTGATTCTGCCACTAGCCCTACT 3´ 
R-GSPnestedMd 5´CTTCCAGTATGGAGCAACCAGACT 3´ 
Full-length Md- Nanog F-fullMd 5´CCTTCCAGCATCTCCTCTAAAAC 3´ 
R-fullMd 5´GATAAGGAGCCCTGGAAAGAGTA 3´ 
 
Table 6. Primers used for cloning chick and opossum Nanog. F, forward and R, reverse. 
 
To analyse the pluripotency enhancers Fgf4 and Sox2, mouse Oct4 and chick Pou2-r 
cDNAs were cloned into pCAGGS vector. These were kind gifts from Drs. H. Kondoh 
(Graduate school of frontier biosciences, Osaka, Japan) and J. Rodríguez-León, (CMRB, 
Barcelona, Spain) respectively. The pCAGGS vector contains a ubiquitous and strong 
chick beta-actin promoter that drives cDNA expression (Niwa et al., 1991). 
For electroporation, the chick full-length Nanog cDNA was cloned from pGEM-T easy 
vector (Promega) into pCAGGS/SE, a kind gift from Dr. M Torres (CNIC, Madrid, Spain). 
The pCAGGS/SE vector includes a greater number of restriction sites 3´ of the 
promoter than the original pCAGGS vector (Stuhmer et al., 2002); the Nanog cDNA was 
cloned into the EcoRI site.  
7. ES cell culture and transfections 
Mouse ES cell line E14 was used to test the activity of the Fgf4 and Sox2 EP enhancers. 
These ES cells were grown on gelatine-coated plates without feeders in Dulbecco´s 
modified Eagle’s medium supplemented with LIF, 15% fetal calf serum, 1mM 
glutamine, 1mM sodium pyruvate, non essential amino acids and 100μM beta-
mercaptoethanol. Transient transfections were performed as previously described 
(Robertson et al., 2006) using in this case 12 μl of Lipofectamine 2000 (Invitrogen) and 
   Materials & Methods 
  39 
2.5μg of each construct. The pPyCAG-GFP vector (a kind gift from Dr I. Chambers, CMR 
Edinburgh, UK) was co-transfected in all cases as an internal control for efficiency. Cells 
were examined 24 h later and for each well, cells expressing lacZ and GFP were 
counted in four random and independent fields (average 300 cells per field). The 
number of lacZ positive cells was normalized with respect to GFP positive cells, and the 
value obtained for the Oct4 distal enhancer was assigned the value of 1. Negative 
controls included a mock transfection (only pPyCAG-GFP) and the empty vector. Three 
independent transfections were carried out for each construct. 
To test the function of mouse Oct4 and chick Pou2-r on the Fgf4 or Sox2 pluripotency 
enhancers, we used mouse E14 and ZHBTc4 ES cells (a kind gift from Dr I. Chambers, 
CMR, Edinburgh, UK). E14 ES cells were transfected under the same conditions as 
above with different combinations of the overexpressing constructs: mouse Oct4 or 
chick Pou2-r cloned into pCAGGS, together with the different versions of the Fgf4 and 
Sox2 enhancers. Relative activity of enhancer elements was determined as the 
proportion of lacZ positive cells for each combination of reporter and expression 
constructs. ZHBTc4 ES cells, in which Oct4 expression can be repressed by the addition 
of tetracycline (Niwa et al., 2000), were cultured as above and transfected under the 
same conditions with the Oct4-DE construct using mRFP as reporter, together with 
mouse Oct4, chick Pou2-r, or empty pCAGGS vector. When required, tetracycline 
(10ng/ml) was added after 24 hours, and reporter activity was measured 48 hours 
after transfection. 
The Nanog-null mouse ES line RCNβH(t) (Chambers et al., 2007), a kind gift from Dr. I 
Chambers (CRM, Edinburgh, UK), was used to analyse the functional equivalence 
between mouse, opossum and chick Nanog proteins. The Nanog-null ES cells were 
grown under the same conditions as the E14 cells but with the addition of hygromycin 
B (50µg/ul) to select the cells in order to maintain the mutation. For stable 
transfections 107 cells were electroporated at 3uF, 0.8 kV (gene pulser, Biorad) with 
100ug of vector linearized with ScaI. As controls, we included empty pPyCAG and mock 
transfection (only electroporation). Cells were plated at 5 x 10 5 cells per 9cm plate. 
Selection started after 48 hours with the addition of 1ug/ml puromycin to culture 
medium with or without LIF. Puromycin was administered every two days until mock 
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plates were clear, usually in 12 days. Colonies were stained with an Alkaline 
phosphatase kit (Sigma) and classified as fully differentiated, mixed or 
undifferentiated. 
8. Embryo transgenesis 
Transient transgenic blastocysts were generated by pronuclear injection as described 
(Nagy et al., 2003). Each construct was micro-injected at a concentration of 4ng/μl and 
embryos were cultured in microdrops of M16 medium (Sigma) covered with mineral oil 
(Sigma) at 37°C, 5% CO2 until blastocyst stage, fixed in 1% formaldehyde, 0.2% 
glutaraldehyde, 2mM MgCl2, 5mM EGTA, and 0.02% Igepal for 5 min at room 
temperature, washed in PBS, and stained for betagalactosidase activity as described 
(Andras Nagy 2003) for 24 hours at room temperature in the dark. A minimum of 50 
blastocysts were used per construct to calculate the percentage of positive embryos. 
The empty vector containing only the minimal promoter and the lacZ reporter was 
used as a negative control, as positive control we used the Oct4-DE. 
9. Electroporation  
Chick embryos were electroporated with Nanog in pCAGGS/SE at concentrations 
ranging from 0.1 to 2ug/ul together with pCAGGS-GFP (0.2ug/ul) to monitor the area 
and efficiency of electroporation. Control embryos were electroporated with empty 
vector and pCAGGS-GFP. Electroporation was performed as described (Uchikawa et al., 
2004). Briefly the egg was broken into a dish, and the HH4 stage embryo was adhered 
to a ring of filter paper through the vitelline membrane. The embryos were placed 
upside down onto the electrode (cathode) and the DNA solution injected between the 
blastoderm and the vitelline membrane using a glass capillary. An anodal electrode 
was quickly placed on the hypoblast side of the embryo and electroporation 
performed with 5 pulses of 7 V for a duration of 50msec and with intervals of 100msec 
(electroporator Intracel TSS20). The embryos were then incubated on agar culture 
medium made of liquid albumen, 0.15% glucose, 61.5mM NaCl and 0.3% noble agar at 
38°C and 100% humidity. GFP expression can be detected about 4 hours after 
electroporation and for as long as 72 hours afterwards. The embryos of interest were 
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then fixed in 4% paraformaldehyde and stored at –20°C until processing for in situ 
hybridization or inmunohistochemistry (Fig 4). 
 
 
 
Figure 4. Electroporation of chick embryos to overexpress chick Nanog. Electroporation 
involves application of an electric field to the embryo that transiently disrupts the stability of 
the cell plasma membrane, thus creating reversible pores through which the plasmids can be 
transported into the cytosol .Modified from (Uchikawa, 2008). 
 
 
 
Nanog overexpression assays in ES cells were performed during a short-term stay at 
the laboratory of Dr. Ian Chambers, Center for Regenerative Medicine, Edinburgh, UK.  
Initial chick embryo electroporations, in situ hybridizations and vasa 
immunohistochemistry were performed during a short-term stay at the laboratory of 
Dr. Hisato Kondoh, Graduate school of frontier biosciences, Osaka University, Japan. 
In situ hybridizations, chick microarrays and ES cell culture were done in collaboration 
with Dr. Susana Cañon. Reporter constructs, ES cell culture and embryo transgenesis 
were carried out in collaboration with Dr. Bárbara Pernaute and Teresa Rayón.  
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1. A COMPARATIVE ANALYSIS OF EMBRYONIC PLURIPOTENCY 
NETWORKS BETWEEN MOUSE AND CHICK 
 
1.1 Identification of an Oct4 paralogue in chick 
At the start of this research project, homologues of the mammalian core factor Oct4 
(official name Pou5f1) had been described from various non-mammalian vertebrates 
(Bachvarova et al., 2004; Burgess et al., 2002; Morrison and Brickman, 2006). All these 
studies claimed that such genes were true homologues of mammalian Oct4 based on 
sequence similarity, early embryonic expression, conservation of synteny (Burgess et 
al., 2002; Morrison and Brickman, 2006), or functional conservation in tissue culture 
assays (Lavial et al., 2007; Morrison and Brickman, 2006). However, their relationships 
were never assessed from a comparative genomic perspective. Therefore we decided 
to analyse the evolutionary history of Oct4 in vertebrates before further analysis of the 
core network in chick. 
By in silico analysis of the chick genome we identified a Pou-domain containing gene, 
with high similarity to Oct4 and identical to the cPouV gene described by (Lavial et al., 
2007). We also analysed the opossum (Monodelphis domestica) genome, a marsupial, 
and surprisingly found two genes highly related to Oct4. Phylogenetic analysis revealed 
that one of the opossum peptides was more related to the chick peptide than to the 
other opossum sequence, the latter grouping with human OCT4 (Fig. 1). The chick 
gene, opossum gene and other genes related to them were named as Pou2-related 
(Pou2-r) and the second opossum gene and related genes as Oct4-related (Oct4-r) (Fig. 
1). We referred collectively to all Pou2-r or Oct4-r genes as Pou5. 
We next examined the genomic location of chick and opossum genes and analysed 
their conservation of synteny with other vertebrate species (Fig. 2). Chick and opossum 
Pou2-r genes are located in a region of conserved synteny with teleost fish and 
Xenopus Pou5 genes. This region also shows extended synteny with the mouse 
genome but however there is no evidence for genes or pseudogenes related to Pou2-r 
in the expected location flanked by Npdc and Fut7 (Fig. 2). However, when we 
examined the location of opossum Oct4 we found that it is in a region of conserved
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 synteny with the mouse Oct4 gene and the green anole lizard (Anolis carolensis). This 
region is also present in Xenopus but harbouring no Oct4 related gene and is not 
conserved in teleost fish. 
Figure 1. Pou5 
phylogenetic tree.  
Phylogenetic analysis of 
the predicted peptide 
sequences from non-
mammalian genes and 
opossum showed that all 
grouped together with 
human OCT4 (red circle) 
and separated from other 
human POU factors. 
Opossum MdPou2-r is 
more related to chick 
GgPou2-r than to the 
other sequence found in 
opossum MdOct4. Xt, 
Xenopus tropicalis; Dr, 
Danio Rerio; Gg, Gallus 
gallus; Md, Monodelphis 
domestica. 
More surprisingly, searches of trace archives and EST databases of the chick genome 
detected no orthologues of genes that flank mouse Oct4 (Fig. 3). Because such genes 
are present in other vertebrates, it is likely that this region has been specifically lost in 
the avian lineage. This view is supported by the fact that mammalian Oct4 is located in 
the extended MHC Class III region, which is conserved with Xenopus but has been lost 
in chick and other avians (Deakin et al., 2006). Previous claims of conserved synteny 
between zebrafish and Xenopus Pou2-r genes and mammalian Oct4 (Burgess et al., 
2002; Morrison and Brickman, 2006) were surely confused by the fact that there is 
linkage of both Pou2-r and Oct4 to members of the chloride intercellular channel 
family (Clic3 and Clic1, respectively; Fig. 2) 
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Figure 2. Synteny analysis shows the genomic region containing Oct4 is lost in avians. Chick 
Pou2-r is located in a region of conserved synteny with that of other Pou2-related genes from 
non-mammalian vertebrates, but different from mouse Oct4. The opossum has two Pou5-like 
genes, one in conserved synteny with chick Pou2-r, and another with mouse Oct4. In the case 
of the anole lizard, an orthologue of Oct4 is detected in conserved synteny with mouse, but 
not an orthologue of Pou2-r, but we believe this is due to the lack of genome coverage in the 
region. Triangles below the opossum and mouse indicate the location of the MHC class III 
cluster.  
 
 
Figure 3. Orthology maps of Oct4 and Nanog. Orthology maps show that the chick genome 
lacks orthologues for many genes that map in the vicinity of mouse (m) or opossum (o) Oct4, 
but are present in Xenopus (x) or zebrafish (z). In contrast, genes surrounding mouse Nanog 
show a distribution of orthologues in different vertebrates that relates to their evolutionary 
distance from mouse. The positions of mouse Oct4 and Nanog are indicated by green lines. 
Presence of orthologues is indicated in red and absence with an empty space. 
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Such findings mean that the exact time of duplication of the ancestral vertebrate Pou5 
gene cannot be assigned with certainty to the base of the mammalian lineage, since it 
could have occurred before the divergence of the avian lineage and was subsequently 
lost as part of the whole region. The existence of the unambiguous Oct4 orthologue in 
the lizard genome suggests that the duplication of the ancestral Pou5 gene occurred 
before the divergence of amniotes. The exact time of the duplication is unknown; 
despite our efforts to relate a Pou5 gene from the amphibian axolotl to Oct4 or Pou2-r 
genes, we failed due to the lack of genome coverage in the region. 
A phylogenetic tree shows the relationships of the species and the duplications and 
losses during the evolutionary history of Pou2-r/Oct4 (Fig. 4). 
 
 
 
 
 
 
 
 
Figure 4. Phylogenetic tree Pou2-r/Oct4 .The tandem duplication that originated three Pou2-r 
genes in Xenopus is indicated. The exact time of the duplication of the ancestral Pou2/5 gene 
to give raise to the Pou2-r (black line) and Oct4 (red line) genes is uncertain (indicated as a 
dashed red line), phylogenetic analysis of the Oct4-related gene from the amphibian axolotl 
places it closer to Oct4 than to Pou2-r genes. However, the lack of genomic data from axolotl 
precludes completing this analysis with synteny information. In a similar fashion, at this stage 
we are uncertain about the existence of a lizard Pou2-r gene due to lack of genomic 
information (dashed black line). 
We can build an evolutionary scenario in which a duplication of an ancestral Pou2/5 
gene occurred before the divergence of amniotes and subsequent losses occurred in 
avians (Oct4) and eutherian mammals (Pou2-r). Consequently, chick Pou2-related is 
not the orthologue of the pluripotency gene Oct4 and other vertebrate Pou5 genes, 
but a paralogue. 
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1.2 Expression of the core network factors in the early chick  
We next decided to examine the expression at pre-gastrulation stages of the chick 
orthologues of the core EP-GRN. While the expression of Pou2-r and Nanog had been 
already described (Canon et al., 2006; Lavial et al., 2007) no studies report the 
expression in early chick embryos of the other core factor of the network, Sox2. 
We obtained by in situ hybridization identical results to those previously described 
from gastrulation to later stages for Nanog and Pou2-r expression (Canon et al., 2006; 
Lavial et al., 2007). Both genes are expressed in the epiblast at EGK-X but while Nanog 
expression is confined to scattered cells over the epiblast (the PGCs), Pou2-r is 
expressed throughout the embryo. In contrast, no expression of Sox2 was detected at 
the EGK-X until stage HH4 when it is strongly upregulated in the neural plate as 
reported (Fig. 5) (Rex et al., 1997; Uchikawa et al., 2003).  
However Sox2 belongs to the SoxB1 subfamily of Sry-related genes (Schepers et al., 
2002) and both other members of this subfamily (Sox1 and Sox3) can partially 
compensate for Sox2 in the derivation of mouse iPS cells (Nakagawa et al., 2008), what 
could point to redundancy in the role of these factors in embryonic pluripotency. We 
therefore examined the expression of chick orthologues and found that while Sox1 is 
not expressed at stage EGK-X, Sox3 shows low levels of restricted expression in the 
central epiblast at this stage. Later both are expressed in the neural plate as previously 
shown (Fig. 6); (Rex et al., 1997; Uchikawa et al., 2003). The low level of expression of 
Sox3 mRNA we observed in early chick embryos might not represent a broad 
expression over the whole of the area pellucida. Published evidence shows that 
explants from pre-gastrulating chick embryos cultured for 40 hours start to express 
Sox2 and Sox3 protein only if they were taken from the medial region of the area 
pellucida, but not from the lateral aspect (Wilson et al., 2001). Therefore, these papers 
would suggest that already at stage EGK-X, there are differences in the epiblast of the 
area pellucida in the expression of Sox2 and Sox3, further confirming that Sox2 (and 
Sox3) is not expressed in the whole epiblast. 
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Figure 5. Two of the core factors of the EP-GRN, Nanog and Pou2-r are expressed in the 
epiblast in the early chick embryo but no expression is detected for the third, Sox2. At stage 
EGK-X Nanog is expressed in scattered cells over the epiblast, the PGCs, later at HH6, 
expression is confined to the PGCs around the border of the area pellucida and area opaca at 
the germinal crescent. Pou2-r is expressed in the earliest stage EGK-X embryos and shortly 
after is upregulated in the area pellucida. In contrast Sox2 is first expressed in the neural plate 
at HH5. Arrows PCGs; Ao, Area Opaca; Ap, Area Pellucida. 
 
Figure 6. Expression of SoxB1 family 
members in the chick embryo. Sox1 is not 
expressed in the chick embryo at stage 
EGK-X (A), but is clearly expressed at later 
stages (HH11) in the neural plate (B). Sox3 
is expressed at low levels in a restricted 
fashion in the epiblast at stage EGK-X (C) 
and later can be detected in the neural 
plate at stage HH4-5 (D). 
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1.3 Expression of other orthologues downstream of the core network in chick 
We next studied the expression of orthologues of mouse genes that act in the second 
layer of the EP-GRN, directly downstream of the core factors, such as the key signaling 
molecules Fgf4 and Nodal or the transcription factor FoxD3 which is required for 
maintaining pluripotency in the epiblast and in ES cells (Hanna et al., 2002). We also 
analysed the polycomb group gene Phc1, because it is a direct target of the core EP 
factors (Boyer et al., 2005; Loh et al., 2006) , is expressed in ES cells, and maps close to 
the Nanog-Gdf3-Dppa3 pluripotency gene cluster (Canon et al., 2006; Clark et al., 
2004). Mouse orthologues of all these genes are expressed in the epiblast of the 
blastocyst (except for Phc1, whose expression in the early mouse embryo has not been 
reported) and in ES cells, but however none is expressed in the pre-gastrulation chick 
embryo (Stage EGK-X). We detect onset of expression of these genes only at later 
stages, broadly in line with previously described patterns and domains (Fig. 7) 
(Chapman et al., 2002; Kos et al., 2001; Shamim and Mason, 1999; Tomotsune et al., 
2000). 
Orthologues of genes that maintain embryonic pluripotency and early lineages in 
mouse are not expressed in equivalent territories of the pre-gastrulation chick 
embryo. These genes therefore might not have the same function in chick as they 
have in mouse. 
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Figure 7. Chick orthologues downstream of the core factors of the mouse EP-GRN genes are 
not expressed in the epiblast at early pre-gastrulation embryos.  FoxD3 is expressed in the 
node at HH3 earlier than reported (Kos et al., 2001), Phc1 in the neural tube at later stages 
(HH9), a pattern similar to its late expression in the mouse embryo (Tomotsune et al., 2000), 
Fgf4 in the primitive streak at HH4 (Shamim and Mason, 1999), and Nodal in the early 
primitive streak at HH3 (Chapman et al., 2002) and later restricted to its anterior portion 
(HH6).  
1.4 Global expression analysis  
In order to address in a more global fashion the differences between early mouse and 
chick embryos we extended our analysis by carrying out a detailed expression profiling 
of chick blastoderm-derived cells and early developmental stages. We used the pre-
gastrulation stage EGK-X and blastoderm-derived cells, equivalent to mouse blastocyst
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 and ES cells respectively, and representatives of the pluripotency state in mouse. The 
neural-fold stage HH6 was included as representative of a differentiated state. We 
compared the profile of chick orthologues of pluripotency-related genes from mouse 
for each of the samples (HH6, EGK-X, bdC) assuming that if the EP-GRN is conserved 
between mouse and chick, the EGK-X and blastoderm-derived cell (bdC) sets will be 
enriched in pluripotency related genes compared to the HH6 set. We carried out the 
microarrays and compared those genes that were up-regulated in each of the chick 
samples to those that respond in mouse ES cells to changing the levels of the core 
pluripotency factors Oct4, Sox2 and Nanog. The sets of mouse genes were obtained 
from {Sharov, 2008 #531} that includes a meta-analysis of various previous papers 
where such changes in gene expression were analyzed. We found that genes positively 
regulated by the core factors, and therefore candidates to be part of the EP-GRN, are 
not over-represented in EGK-X embryos compared to HH6, and even under-
represented in blastoderm-derived cells. On the other hand, genes that are negatively 
regulated by the core factors, possibly involved in differentiation events after the stage 
of embryonic pluripotency, are not enriched in HH6 embryo compared to EGK-X, and 
over-represented in blastoderm-derived cells (Fig. 8). We obtained similar results 
when we calculated the genes positively regulated independently for each EP factor 
instead for all factors together (Table. 3 Materials and Methods). 
 
 
 
 
 
 
 
Figura 8. Chick orthologues of mouse EP-GRN genes are not enriched in early pre-
gastrulation embryos. Global analysis of gene expression shows that chick orthologues of 
mouse genes that are activated by core pluripotency factors (EP-TF: Oct4, Sox2 and Nanog) are 
equally enriched in genes upregulated in HH6 or EGK-X embryos, as compared to blastoderm-
derived cells (bdC). Genes repressed by core factors show the same trend only that they are 
over-represented in upregulated genes in bdC. *, p < 0.05; **, p < 0.01 (two-tailed Fisher’s 
exact test). 
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We found similar trends when we compared the chick data set with the results of a 
recent single-cell analysis of mouse embryonic pluripotent cells (Tang et al., 2010). In 
this work, the authors compile various data sets of genes that mark different aspects 
of embryonic pluripotency (pluripotent genes, self-renewal, maintenance of 
pluripotency, repressors of pluripotency) as well as ES cell and ICM specific genes. 
Genes defined as pluripotent, ES or ICM specific do not show an over-representation in 
chick EGK-X samples as compared to the post-gastrulation HH6 embryos. Surprisingly, 
blastoderm-derived cells show enrichment in genes classified as repressors of 
pluripotency, as well as a lower proportion of ES-specific or self-renewal genes 
compared to the HH6 embryo (Fig. 9).  
The global expression profiles of pre-gastrulation chick embryo (EGK-X) and 
blastoderm-derived cells are not more similar to the pluripotent state in mouse 
embryos than to the profile in the post-gastrulation chick embryo. This strongly 
suggests the genes that form the mouse EP-GRN are not expressed in a comparable 
fashion in the early chick embryo.  
 
 
 
 
 
 
 
 
 
 
Figure 9. Expression profiling shows no enrichment of orthologues of mouse pluripotency-
related genes in the pre-gastrulation chick. The distribution of orthologues of chick genes 
over-represented in HH6, EGK-X embryos, and blastoderm-derived cells (bdC) in defined sets 
of pluripotency-related genes (Tang et al., 2010) shows that general pluripotent genes are 
equally distributed in the three sets of chick genes, while ES and self renewal genes are over-
represented in the HH6 set. Genes classified as repressors of pluripotency are over-
represented in the bdC set. *, p < 0.05; **, p < 0.01 (two-tailed Fisher’s exact test). 
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1.5 Several pluripotency-related genes are specific to mammals  
We next searched for chick orthologues of mouse genes shown to be downstream of 
the core factors as part of the EP-GRN, or expressed in similar pattern to these core 
factors and have been extensively used as markers of the pluripotent state. Among 
these, we found that in many cases no chick orthologue is present in the available 
genomic and transcriptional databases. This could be due simply to lack of coverage of 
genomic and EST sequences and we therefore examined these cases in detail to 
determine if these genes were unique to the mammalian lineage, as is the case for the 
pluripotency-associated genes Gdf3 and Dppa3, which map adjacent to Nanog (Canon 
et al., 2006).  
The chromosomal regions surrounding the mouse genes Utf1, Tex19.1, Dppa2, Dppa4 
and Dppa5 conserve synteny with the chick genome, but none of these genes is 
present in chick, although their immediate neighbours are (Fig. 10). Extensive searches 
found no evidence for orthologues of these genes in other genomic positions or in 
other databases. Utf1 is a chromatin associated factor involved in controlling the 
initiation of ES cell differentiation and is expressed in the ICM of the blastocyst (Okuda 
et al., 1998; van den Boom et al., 2007). It is a direct functional target of the Oct4/Sox2 
transcriptional complex  (Nishimoto et al., 2005), and it has been shown to enhance 
the efficiency of human iPS cell generation (Zhao et al., 2008). In mouse it is located on 
chromosome 7, near to genes not involved in pluripotency that are present and 
conserve synteny with chick, but Utf1 is specifically missing at that chromosomal 
position (Fig. 10A). Tex19.1 and its tandem duplicate Tex19.2 have been previously 
described as mammal-specific and expressed in pluripotent stem cells (Kuntz et al., 
2008), although this comparison was done with teleost fish and invertebrates and did 
not include chick. It is noteworthy that these genes are adjacent to another pair of 
tandem duplicates present in mouse but not in chick, Sectm1a and Sectm1b (Fig. 10B). 
These genes belong to the Ig superfamily and are closely related to the neighbouring 
Cd7 gene, which is conserved in chick. This indicates that this region has undergone 
extensive duplication and gene gain during mammalian evolution. Dppa5, identified 
because of having an expression pattern similar to Oct4, is flanked by Omt2b (Oocyte 
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maturation beta) and Ooep (Oocyte expressed protein homolog), two other mammals 
specific genes (Fig. 10C). These genes are expressed in a very similar pattern to Dppa5 
in the embryo and ES cells (Popova and Morris, 2004; Tanaka et al., 2006), and 
furthermore Ooep and Dppa5 belong to the same family (Pierre et al., 2007). Dppa2 
and Dppa4 are tandem duplicated genes expressed in the ICM and later in primordial 
germ cells (Maldonado-Saldivia et al., 2007), and interestingly forced expression of 
Dppa4 in ES cells drives them to a primitive ectoderm lineage (Masaki et al., 2007). 
Furthermore, Dppa4 is a direct target of the Oct4/Sox2 transcriptional complex 
(Chakravarthy et al., 2008). The Dppa2/4 duplication must have occurred late in 
mammalian evolution, since the opossum contains only one Dppa2/4 gene (not 
shown). The neighbouring Morc1 gene (microrchidia) is involved in spermatogenesis 
(Inoue et al., 1999), and also has no orthologue in chick (Fig. 10D). Unigene-based EST 
expression profiling (Sayers et al., 2008) shows that this gene is also expressed in the 
pre-implantation mouse embryo.  
Other mouse EP-GRN genes not found in the chick genome are located in regions that 
show no syntenic conservation with chick. Therefore the only support for their being 
specific to mammals is that no orthologues have been found in sequence databases of 
chick or other non-mammalian species. Such is the case of Dppa1 (Bortvin et al., 2003) 
and the miR-290 cluster (Houbaviy et al., 2005; Houbaviy et al., 2003) which are 
nonetheless considered as specific to eutherians. For other genes, additional evidence 
is consistent with their being specific to mammals. For example, the pluripotency 
marker Rex1 (Zfp42), which is a retrotransposed copy of zinc finger transcription factor 
YY1 and appears to be specific to placental mammals (Kim et al., 2007), lies in an 
extremely gene-poor region of mouse chromosome 8 that is enriched in mammal-
specific genes such as Triml1, Adam26a, Adam26b and Adam34. The databases contain 
no chick orthologue of Nac1, a BTB/POZ transcription factor found at the core of the 
EP-GRN (Kim et al., 2008), but orthologues are found in fish and Xenopus. Nac1 is 
located in a region of mouse chromosome 8 (40 Mb from Rex1) where all surrounding 
genes show the same pattern of conservation. This could indicate that the specific 
genomic region containing Nac1 has been deleted in avian evolution, in line with 
  Results 
  54 
recent evidence showing a high level of gene loss in avians compared with other 
vertebrates (Hughes and Friedman, 2008).  
Many genes with pivotal roles in embryonic pluripotency in the mouse are not 
present in the chick, suggesting that they may have arisen specifically in the 
mammalian lineage in connection with the establishment of the EP-GRN. 
 
 
 
 
 
 
 
 
Figure 10. Lack of EP-GRN orthologues in the chick genome. Mouse Utf1 (A), Tex19.1 (B), 
Dppa5 (C) and the tandem duplicates Dppa2 and Dppa4 (D) lie in regions of conserved synteny 
between mouse and the chick, but are absent from the latter. The mouse (Mm) and chick (Gg) 
chromosomes (chr.) where the genes are located are indicated. The diagrams are not shown to 
scale. 
1.6 Core EP-GRN binding cassettes have been acquired in the mammalian lineage  
Previous reports have shown that the core factors of EP-GRN bind to genomics regions 
regulating downstream target genes important to keep ES cells in an undifferentiated 
state.  Moreover these analyses indicate that the core factors co-occupy a substantial 
portion of their targets binding in different configurations in a coordinated manner in 
vivo (Boyer et al., 2005; Loh et al., 2006). Our results above showing that in chick many 
components of the network have different expression domains to those in mouse or 
simply are not present, would predict that the regulatory targets of the core EP 
transcription factors were assembled de novo in mammals.
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To test this, we conducted a genome-wide analysis of those regions bound by the core 
EP transcription factors in ES cells (Marson et al., 2008). This was done by examining 
whole-genome alignments of several vertebrate species: human, dog, rat, mouse and 
chick. We reasoned that if the core of the EP-GRN network (Oct4, Nanog and Sox2) is 
indeed a mammalian novelty, genomic regions bound by these factors (most likely 
corresponding to cis regulatory elements) will be poorly conserved between mouse 
and chick. This comparison is meaningful even taking into consideration the 
evolutionary distance between these species and the fact that there is a considerable 
turnover in specific transcription factor binding sites during evolution (Odom et al., 
2007), as nonetheless sequence conservation can be useful in predicting 
approximately half of functional elements in the genome (ENCODE project consortium, 
2007; Pennacchio et al., 2006; Pennacchio et al., 2007). 
We examined the overall evolutionary conservation of 1688 non coding genomic 
regions bound by, at least, Oct4 and Nanog in ES cells (Marson et al., 2008). Of these 
regions, 11.55% are not conserved between mouse and any other species, over half 
(53.26%) are conserved only in rodents (mouse and rat), approximately a third (32.7%) 
are conserved in mammals (mouse, rat, human and dog), and just 2.49% are conserved 
in chick (Fig. 11A). This figure is extremely low compared with prior estimates of the 
conservation of non-coding regulatory elements between human, rodents and chick 
(Hillier et al., 2004). Nonetheless, to strengthen our conclusion we wished to compare 
the results with a similar dataset from a GRN known to control a biological process 
well-conserved between mouse and chick. For this, we chose the cis-regulatory 
circuitry underlying limb patterning, which is in many instances a prime example of the 
evolutionary conservation of developmental processes in vertebrates. We used the 
data generated in a whole-genome study where they identified the cis-regulatory 
network of Gli3, which plays a crucial role as effector of Shh signalling in the 
developing limb (Vokes et al., 2008). Applying the same approach described for the 
regions bound by the core factors but for the 200 top-scoring genomic regions bound 
by GRN transcription factor Gli3, we found that 26% of these regions are conserved 
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between mouse and chick (Fig. 11A). It is also noteworthy that a higher proportion of 
the Gli3-bound regions are conserved in the other mammals analysed (60.5%, versus 
32.7% for Oct4 and Nanog). This comparison shows that regions bound by Oct4 and 
Nanog, and therefore part of the ES pluripotency GRN, are significantly less conserved 
than those bound by Gli3 as part of the limb development GRN. 
However, there are at least two alternative explanations for the data presented above. 
One possibility is that the majority of regions bound by Oct4 and Nanog in the mouse 
genome are cis-regulatory elements controlling mouse-specific genes that have no 
chick orthologues. Therefore our analysis would only detect mammalian or mouse 
specific EP-GRN targets. This is not the case, since we found that those genes located 
in the vicinity of Oct4-Nanog bound regions have a higher proportion of 1-to-1 chick 
orthologues than the total mouse gene set (61% versus 44%) (Fig. 11C). The second 
possibility is that the low conservation of Oct4-Nanog regions in the chick genome 
could simply be an artefact of their enrichment in mouse- or rodent-only conserved 
regions (Fig. 11A). To test for this, we first counted the number of Oct4-Nanog regions 
conserved between mouse and human, and from this set we counted those regions 
that were also conserved with rat or with chick. We then calculated the relative 
proportions of each grouping (Fig. 11C). Applying this same strategy to whole genome 
comparison, it has been shown that 23.29% of all non-coding regions conserved among 
mouse, human and rat are also conserved in chick (Prabhakar et al., 2006). We found 
that for Oct4-Nanog regions the figure was 8.02% and for Gli3 regions it was 32.3% 
(Fig. 11B, C). Therefore the lack of conservation of Oct4-Nanog bound regions between 
mouse and chick is still significant when mouse and rodent-specific genomic regions 
are excluded from the analysis. 
EP-GRN was newly assembled during the evolution of mammals, partly through the 
recruitment of pre-existing genes by the appearance of core EP factor response 
elements.
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Figure 11. Genomic regions bound by Oct4 and Nanog are poorly conserved in chick. A) A 
high proportion of Oct4-Nanog bound regions (black bars) are specific to mouse or conserved 
only in rodents, compared with regions bound by Gli3 (white bars), part of the limb 
development GRN. Oct4-Nanog and Gli3 bound sites are enriched in regions conserved 
between mammals. Very few of the Oct4-Nanog bound regions are conserved with chick, 
compared with those bound by Gli3 (2.49 vs. 26%). B) Grouping of regions bound by Oct4 and 
Nanog in mouse ES cells, and by Gli3 in the mouse limb that are conserved between mouse 
and human, and then with rat or with chick C) Oct4-Nanog set is significantly enriched in genes 
conserved in chick compared to the whole genome (p-value<0.0001; two-tailed Chi-square 
test). There are 1688 regions, giving an output of 1591 genes. We do not know if the difference 
comes from multiples regions for one gene, or some Ensembl IDs being wrong. D) The set of 
Oct4-Nanog bound regions has an equal proportion of conserved mammalian non-coding 
elements as the Gli3 set (mhr/mh), but a much lower number of regions conserved in chick 
(mhc/mh). mh, number of genomic regions conserved between mouse and human; mhr, 
regions conserved between mouse and humans that are also conserved in rat; mhc, regions 
conserved between mouse and humans that are also conserved in chick. Except for the 
mhr/mh comparison, all differences between the Oct4- Nanog and Gli3 data sets are highly 
significant (p < 0.0001 two-tailed Fisher’s exact test). 
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1.7 Conservation and evolution of the Fgf4 and Sox2 EP enhancers  
To further explore and refine the above scenario, we tried to identify specific cases 
where we could trace the appearance of a core EP-GRN regulated element. We 
focused on elements that have been shown to possess cis-regulatory activity in vivo in 
response to core EP factors. The best characterized set of such regulatory elements 
corresponds to Sox2/Oct4 regulated genes in which adjacent HMG and POU binding 
motifs mediate high transcriptional activity (Remenyi et al., 2003). To date, functional 
HMG/POU cassettes have been characterized in detail from eight Sox2/Oct4 target 
genes, namely Sox2 and Oct4 themselves plus Nanog, Lefty1, Fgf4, Fbxo15, Utf1 and 
Dppa4 (Nakatake, 2006 #471; Chakravarthy, 2008 #469 and references therein). Only 
for Fgf4 and Sox2 we found that the genomic region containing the HMG/POU cassette 
shows a partial but significant degree of conservation between mouse, other mammals 
and chick (Fig. 12A, B). In other cases, either there is no orthologue in chick (as for 
Dppa4, Utf1 and Oct4 (Fig. 10 A, D and 3), or no similarity at all between mouse and 
chick genomic regions can be detected (as occurs for Nanog). 
The Fgf4 HMG/POU cassette is located in the 3’ UTR of the gene, and genomic 
fragments carrying these sites drive reporter expression in embryonic carcinoma (EC) 
cells, ES cells and the ICM of E4.5 blastocysts. This expression is strictly dependant on 
the synergistic action of Sox2 and Oct4 (Chakravarthy et al., 2008; Fraidenraich et al., 
1998; Yuan et al., 1995), To examine the conservation of these sites and surrounding 
regions we aligned the 3’ UTR of mouse Fgf4 (2.3 kb) to 3 kb of genomic sequence 
immediately downstream from the stop codon of the coding region of Fgf4 
orthologues from other vertebrates (Fig. 12A). We found various peaks of conservation 
distributed along the length of the mouse 3’ UTR and noticed that the Sox2/Oct4 
binding site (thin blue line in Fig. 12A) was adjacent to a region conserved among 
mammals and chick. In this last case, sequence conservation was sufficient to anchor 
an alignment that contained the HMG/POU cassette (Fig. 12C). The HMG half of the 
cassette is identical in all species except for a single change in the 5’ end in the chick 
sequence (A instead of C). Intriguingly, this is one of the invariable residues in all 
Sox2/Oct4 composite sites identified to date in mouse (Chew et al., 2005). Regarding 
Results 
59 
the POU site, both chick and platypus show several nucleotide changes and a one base 
deletion. 
The Sox2 HMG/POU cassette localizes approximately 2.5 kb downstream of the stop 
codon in mouse and is contained in one of the two elements found in the vicinity of 
Sox2 shown to be active in pluripotent cells (Tomioka et al., 2002). We aligned 4 kb 
downstream from the stop codon of the mouse gene to the equivalent regions from 
other vertebrates. As with Fgf4, conservation was distributed along the length of the 
sequence and the Sox2/Oct4 binding site was located in a region highly conserved 
among all mammals, and poorly but still detectably conserved in chick and lizard (Fig. 
12B). This region does not correspond to any of the multiple conserved elements 
previously described to act as enhancers in the early chick embryo (Uchikawa et al., 
2003). Closer examination showed that unlike the Fgf4 enhancer, the Sox2 enhancer of 
non-eutherian mammals contains a perfect POU site, and the HMG site contains only 
two changes; however, once again these affect the C residue in the first position, 
invariant in all other Sox2/Oct4 sites (Fig. 12D). The chick sequence is altered with 
respect to the mouse at multiple positions in both the HMG and the POU sites (Fig. 
12D).  
Based on studies of other Sox2/Oct4 elements, the nucleotide changes we observe in 
chick compared to the mouse Fgf4 and Sox2 enhancers would be predicted to abolish 
Oct4 and Sox2 binding and therefore enhancer activity, (Chakravarthy et al., 2008; 
Chew et al., 2005; Kuroda et al., 2005; Rodda et al., 2005) 
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Figure 12. Conservation of the Fgf4 and Sox2 EP enhancers. (A, B) Vista plots comparing the 
3’UTR from mouse Fgf4 (A) and the 4 kb downstream of the mouse Sox2 stop codon (B) with 
orthologous regions from other vertebrates. Regions ≥100 bp that show 60% (50% in the case 
of non-mammalian species) or greater sequence identity to the mouse sequence are coloured 
pink, and Sox2/Oct4 binding site (BS) is shown in blue. (C, D) Sequence comparison of the 
regions surrounding the Sox2/Oct4 BS from Fgf4 (C) and Sox2 (D). The HMG and POU sites are 
indicated below the sequence and are highlighted red. Residues identical across at least five 
species are shown with a black background. Dashes indicate gaps introduced to maximize the 
alignment. Opossum and zebrafish Fgf4 sequences do not align in this region. 
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1.8 Activity of the Fgf4 and Sox2 EP enhancers in pluripotent cells  
In order to test the enhancer activity of mouse and chick genomic regions from Fgf4 
and Sox2, we cloned them in an enhancer-detection vector and tested their activity in 
mouse ES cells and in transgenic pre-implantation embryos (Fig. 13). As a positive 
control, we used the previously described Oct4 distal enhancer (Oct4-DE; Fig. 13B) that 
contains the Sox2/Oct4 binding sites and is active in both ES cells and in the inner cell 
mass of the blastocyst (Yeom et al., 1996). As expected, both mouse fragments were 
able to drive expression of the reporter in ES cells, but only the Fgf4 enhancer was 
active in the blastocyst transgene assay we used (Fig. 13C). On the contrary, the chick 
fragments showed much lower activity in ES cells, and the chick Fgf4 fragment was not 
active in the blastocyst (Fig. 13D). We then proceeded to change the sequence of the 
Sox2/Oct4 sites from the mouse Fgf4 and Sox2 enhancers to that of the equivalent 
position in the chick sequences. This dramatically reduced expression of the reporter in 
ES cells (six-fold for Fgf4, and ten-fold for Sox2) (Fig. 13A) and abolished activity of the 
Fgf4 enhancer in the blastocyst, confirming that bona-fide Sox2/Oct4 binding sites are 
necessary for enhancer activity. To test if the mouse sequence of these sites was 
sufficient for activity in ES cells, we mutated the corresponding base pairs in the chick 
fragments to those found in mouse. However, this was not sufficient to make the chick 
fragments active in ES cells, as the mutated fragments showed no significant changes 
as compared to the wild types (Fig. 13A) and the mutated chick Fgf4 fragment was not 
active in the blastocyst. Experimental evidence for the case of Sox2 has shown that 
changes in downstream positions that are not conserved either between chick and 
mouse also contribute to enhancer activity (Fig. 14) (Chakravarthy et al., 2008; 
Tomioka et al., 2002). This, together with our results, shows that sequences other than 
the Sox2/Oct4 cassette contained in the mouse enhancers, and not conserved with 
chick, are also needed for correct expression in pluripotent cells. 
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Figure 13. Activity of the Fgf4 and Sox2 EP enhancers. (A) Relative enhancer activity in ES cells 
of the genomic fragments from the Fgf4 and Sox2 locus of mouse (Mm) and chick (Gg), as  well 
as versions where the mouse Sox2/Oct4 site were changed to the equivalent chick sequence 
(Mm→Gg), or the chick sequence was changed to include the mouse Sox2/Oct4 site 
(Gg→Mm). Transfection efficiency was normalized and expressed as relative value with 
respect to the activity of the Oct4 distal enhancer (Oct4-DE). (B-D) Enhancer activity in 
transgenic mouse blastocysts of the mouse Fgf4 3’UTR enhancer (C) and the equivalent chick 
genomic region (D). In this last case, the embryo shown is representative for the unspecific 
punctuated pattern equal to that obtained even when the empty vector is used, as well as for 
the mutated versions of both the mouse and chick fragments. The activity of the mouse Oct4-
DE in the inner cell mass is shown as a positive control (B). 
 
A possibility that is not ruled out by the above experiments is that the nucleotide 
differences we observe in the chick genome correlate with changes in the binding 
specificities of the factors. While mouse and chick Sox2 peptides are almost identical 
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(Fig. 15A), ruling out drastic changes in binding specificities, mouse Oct4 and its 
paralogue chick Pou2-r show much greater divergence (Fig. 15B) (Lavial et al., 2007). 
 
Figure 14. Alignment of the Sox2/Oct4 
binding site and 3’ adjacent sequences 
from mouse Sox2 with chick and mutant 
versions that significantly affect 
enhancer activity. All mutations were 
tested by (Tomioka et al., 2002), except 
for the (Sox2)14G mutation, which was 
tested by (Chakravarthy et al., 2008). 
Dashes indicate gaps introduced to 
maximize the alignment; dots indicate 
residues identical to the mouse 
sequence. 
 
A 
Mm  MYNMMETELKPPGPQQASGGGGGGGNATAAATGGNQKNSPDRVKRPMNAFMVWSRGQRRKMAQENPKMHNSEISKRLGAE  
Gg  MYNMMETELKPPAPQQTSGGG--TGNSNSAAN--NQKNSPDRVKRPMNAFMVWSRGQRRKMAQENPKMHNSEISKRLGAE  
 
Mm  WKLLSETEKRPFIDEAKRLRALHMKEHPDYKYRPRRKTKTLMKKDKYTLPGGLLAPGGNSMASGVGVGAGLGAGVNQRMD  
Gg  WKLLSEAEKRPFIDEAKRLRALHMKEHPDYKYRPRRKTKTLMKKDKYTLPGGLLAPGTNTMTTGVGVGATLGAGVNQRMD  
 
Mm  SYAHMNGWSNGSYSMMQEQLGYPQHPGLNAHGAAQMQPMHRYDVSALQYNSMTSSQTYMNGSPTYSMSYSQQGTPGMALG  
Gg  SYAHMNGWTNGGYGMMQEQLGYPQHPGLNAHNAAQMQPMHRYDVSALQYNSMTSSQTYMNGSPTYSMSYSQQGTPGMALG  
 
Mm  SMGSVVKSEASSSPPVVTSSSHSRAPCQAGDLRDMISMYLPGAEVPEPAAPSRLHMAQHYQSGPVPGTAINGTLPLSHM  
Gg  SMGSVVKTESSSSPPVVTSSSHSRAPCQAGDLRDMISMYLPGAEVPEPAAPSRLHMSQHYQSAPVPGTAINGTLPLSHM  
 
 
B 
Mm  MAGHLASDFAFSPPPGGGDGSAGLEPGWVDPRTWLSFQGPPGGPGIGPGSEVLGISPCPPAYEFCGGMAYCGPQVGLGLV  
Gg  --------------------------MHVKAKNLLRMCKWLKGLRNARGS-TWGRS---------G-----------GRK  
 
Mm  PQVGVETLQPEGQAGARVESNSEGTSSEPCADRPNAVKLEKVEPTPEESQDMKALQKELEQFAKLLKQKRITLGYTQADV  
Gg  PMRSSGRLPRSADPGWGNHANRAAVVTRGISSHSPRVCLCLCQDAPTS--------EELEQFAKDLKHKRIMLGFTQADV  
 
Mm  GLTLGVLFGKVFSQTTICRFEALQLSLKNMCKLRPLLEKWVEEADNNENLQEICKSET-LVQARKRKR-TSIENRVRWSL  
Gg  GLALGTLYGKMFSQTTICRFEALQLSFKNMCKLKPLLQRWLNEAENTDNMQEMCNAEQVLAQARKRKRRTSIETNVKGTL  
 
Mm  ETMFLKCPKPSLQQITHIANQLGLEKDVVRVWFCNRRQKGKRSSIEYSQREE---YEATGTPFPGGAVSFPLPPGPHFGT  
Gg  ESFFRKCVKPSPQEISQIAEDLNLDKDVVRVWFCNRRQKGKRLLLPFGNESEGVMYDMNQSLVPPG---LPIP----VTS  
 
Mm  PGYGSPHFTTLYSVPFPEGEAFPSVPVTALGSPMHSN  
Gg  QGYSLAPSPPVYMPPFHKAEMFPPPLQPGISMNNSSH  
 
Figure 15. Alignment of the predicted proteins of Sox2 and Oct4 genes. (A) Mouse and chick 
Sox2 proteins show overall similarity of 92% (B) Mouse Oct4 and chick Pou2-r proteins only 
37%.  Mm, Mus musculus; Gg, Gallus gallus. 
We therefore tested the transcriptional activity of mouse Oct4 and chick Pou2-r on the 
different mouse pluripotency enhancers and equivalent genomic regions from chick. In 
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a first set of experiments we use the mouse ES cell line ZHBTc4, where the addition of 
tetracycline to the culture leads to silencing of Oct4 (Niwa et al., 2000). Upon 
transfection of mouse Oct4 or chick Pou2-r and in the absence of tetracycline, the 
activity of Oct4-DE is increased due to the effects of the exogenous Oct4 and Pou2-r 
proteins. Upon silencing with tetracycline, endogenous Oct4 is repressed and 
consequently Oct4-DE activity is lost. However when mouse Oct4 or chick Pou2-r are 
overexpressed both are equally able to bind to Oct4-DE and activate the enhancer, 
rescuing its activity (Fig. 16A). 
The E14 ES cell line, more robust in reporter expression assays, was used to test the 
response of Fgf4 and Sox2 chick fragments to Pou2-r overexpression. Even though 
these cells do not have an inducible-repression system for Oct4, the experiment above 
demonstrated we are able to detect differences in enhancer activity in the presence of 
endogenous Oct4 (Fig 16A tet-). The overexpression of chick Pou2-r did not have any 
effect on chick genomic fragments from Fgf4 or Sox2 or on mutated version of the 
mouse enhancers where nucleotide residues in the binding sites had been changed to 
those present in chick (Fig. 16B). Therefore Pou2-r is not able to bind them, confirming 
the chick fragments do not contain cryptic POU binding sites that respond specifically 
to chick Pou2-r. 
The binding specificities of chick Sox2 and Pou2-r are conserved with mouse. 
However, regions in the chick genome corresponding to Sox2/Oct4 responsive 
elements in the mouse genome cannot be bound by these factors because they lack 
critical sequences. The number of nucleotide differences between the chick and 
mouse sequences is small enough to have arisen by point mutation and insertion. 
Thus, modest changes led to the appearance of novel regulatory elements under the 
control of Sox2 and Oct4, as part of the emerging EP-GRN during mammalian 
evolution.
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Figure 16. Overexpression of mouse Oct4 and chick Pou2-r have similar effects on 
pluripotency enhancers in ES cells. (A) The activity of the Oct4 distal enhancer (Oct4-DE) in 
ZHBTc4 ES cells is increased by the overexpression of both mouse Oct4 and chick Pou2-r in 
similar degree (tet-). Shut-down of endogenous Oct4 expression by the addition of tetracycline 
(tet+) abolishes the activity of the Oct4-DE (empty), but enhancer activity is recovered when 
mouse Oct4 or chick Pou2-r are overexpressed. Relative activity of the enhancer element was 
determined by the reporter mRFP expression (B) Mouse Fgf4 and Sox2 pluripotency enhancers 
(Mm Fgf4, Mm Sox2) respond in a similar degree to overexpression of mouse Oct4 or chick 
Pou2-r in E14 ES cells. Neither the chick genomic regions equivalent to the mouse enhancers 
(Gg Fgf4, Gg Sox2) nor the mouse enhancers where the Sox2/Oct4 site was changed to the 
equivalent chick sequence (Mm Fgf4→Gg, Mm Sox2→Gg) showed any increased response to 
overexpression of chick Pou2-r. The activity of the Oct4-DE is shown as a control. Relative 
activity of enhancer elements was determined by the lacZ reporter expression. Standard 
deviation bars are shown. 
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2. FUNCTIONAL ANALYSIS OF VERTEBRATE NANOG FACTORS 
2.1 Conservation and divergence of Nanog proteins 
Nanog is a divergent homedomain protein found in pluripotent mammalian embryo 
cells, in derived ES cells and in developing germ cells. Nanog mediates the naïve 
epiblast pluripotent ground state and is indispensable for the formation of germ cells 
(Chambers et al., 2007; Silva et al., 2009). Nanog orthologues have been identified in 
several vertebrates (Canon et al., 2006; Dixon et al., 2010; Lavial et al., 2007) and the 
alignment of their predicted proteins has revealed intriguing differences with mouse 
Nanog, particularly in a region crucial for its biological function (Mullin et al., 2008; 
Wang et al., 2008). In eutherian mammals this region contains repeated motifs in 
which every fifth amino acid is tryptophan, and this region is essential for formation of 
a functional dimeric Nanog protein. These motifs are present in ten copies in mouse 
and eight copies in human. However, opossum Nanog contains only two copies, and 
the chick orthologue contains none (Fig. 17). To test the functional significance of this 
difference, we compared vertebrate Nanog proteins in functional assays in mouse ES 
cells. 
 
 
 
 
 
 
Figure 17. Schematic representation of the predicted Nanog protein structures in (A) mouse, 
(B) opossum and (C) chick. The conservation is the highest in the homedomain. The five amino 
acid tryptophan repeat motif is present in ten copies in mouse Nanog (A, blue), two copies in 
opossum (B, blue) and none in chick (C, blue). Domains that are less than 50% similar to mouse 
Nanog are coloured grey. ND, N-terminal domain; HD, homedomain; CD1, CD2, C-terminal 
domain 1 and 2; WR, dimerization or tryptophan repeat domain; Mm, Mus musculus; Md, 
Monodelphis domestica; Gg, Gallus gallus. Modified from (Chambers and Tomlinson, 2009). 
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2.1.1 Functional equivalence of vertebrate Nanog proteins 
Mouse Nanog function was originally described in mouse ES cells; Nanog over-
expression in these cells can bypass the requirement of LIF and maintain ES 
pluripotency (Chambers et al., 2003). Therefore ES cells are a good system to test the 
function of chick Nanog. We also analysed the Nanog orthologue of the marsupial 
opossum. Nanog null mouse ES cells (Chambers et al., 2007) were stably transfected 
with vectors containing mouse, opossum or chick Nanog. Since these cells lack 
endogenous mouse Nanog, we could explore the extent to which opossum or chick 
Nanog overexpression sustains self-renewal after LIF withdrawal. Pluripotency of the 
ES colonies after transfection was assessed by alkaline phosphatase staining, and 
colonies were classified as undifferentiated, mixed or fully differentiated (Fig. 18). Both 
orthologues were able to maintain colonies with a normal ES morphology and the 
stable clones retained self-renewal and pluripotency after several passages. 
Despite the sequence divergence between mouse Nanog and the Nanog orthologues 
from opossum and chick, these proteins are functionally equivalent in mouse ES 
cells. 
Figure 18.Functional equivalence of mouse, opossum and chick Nanog proteins in Nanog-null 
ES cells. Percentages of three categories of colonies stained for alkaline phosphatase: 
differentiated, mixed or undifferentiated. In the absence of Nanog (empty) only mixed or 
differentiated colonies are found in the no LIF condition. In the absence of LIF, expression of 
Nanog sustained the undifferentiated state to a similar extent irrespective of the species of the 
protein (34% of colonies for mouse Nanog, 42% for opossum, and 30% for chick). 
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2.2 Downstream targets of Nanog in vertebrates 
Functional equivalence in tissue culture assays indicate that chick Nanog is able to bind 
to mouse Nanog targets in ES cells but it does not imply it has the same functioning or 
networking in vivo. In fact, the different Nanog expression patterns (Canon et al., 
2006) and our previous results on EP-GRN would suggest that the range of Nanog 
targets differs between mouse and chick. We aimed to elucidate the differences by 
comparing the actions of overexpressed Nanog in both species in vivo.  
2.2.1 Nanog overexpression in the chick embryo  
Chick Nanog was overexpressed in chick embryos by electroporation. This method of 
transient transgenesis allows efficient overexpression of a cDNA cloned into a vector 
containing a strong promoter. By applying an electric field, the construct can be 
delivered into the cells of the embryo. In this manner, we overexpressed chick Nanog 
in the epiblast cells of HH4 chick embryos, the earliest stage at which this approach is 
technically possible. In all cases, empty vector (control) or Nanog was co-
electroporated with a GFP-expressing construct to mark the area of electroporation 
(Fig. 19, 20, 21).  
We next examined the expression of Pou2-r and Sox2, the homologues of the core EP-
GRN factors that are upregulated by Nanog (Boyer et al., 2005; Wang et al., 2006) We 
also analysed the orthologues of Eomes and Cdx2, which specify extraembryonic fate 
in mouse development and are repressed by Nanog in the embryonic lineage and in ES 
cells (Chen et al., 2009).  
In control embryos Pou2-r expression was detected as described (Lavial et al., 2007), 
while in embryos overexpressing Nanog, Pou2-r was upregulated (Fig. 19A). In mouse 
ES cells even though Oct4 expression is activated by Nanog it also repressed by Oct4 
itself. Therefore Nanog overexpression fails to increase Oct4 beyond the steady-state 
concentration (Pan et al., 2006). These results suggest that in chick this Oct4 
autoregulatory loop might not be present.  
Conversely, Nanog overexpression did not alter the Sox2 expression pattern in the 
neural tube, cephalic placodes or its derivates (Rex et al., 1997; Uchikawa et al., 2003) 
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(Fig. 19B), despite the fact that Nanog positively regulates Sox2 expression in mouse ES 
cells (Boyer et al., 2005). Since Sox3 is expressed in part of the epiblast at stage EGK-X 
but Sox2 is not, we therefore examined Sox3 expression, in order to exclude an 
exchange in the response of these two factors to Nanog. Nanog overexpression had no 
effect on the Sox3 expression pattern (Fig. 19C) (Rex et al., 1997).  
 
Figure 19. Nanog overexpression causes upregulation of Pou2-r but does not change Sox2 or 
Sox3 expression. (A) In controls, Pou2-r is detected in PGCs and in neural tissue; in Nanog 
overexpressing embryos (Nanog) Pou2-r is upregulated in the electroporation area. B) In 
controls, Sox2 is detected in the neural tube and the cephalic placodes and its derivates; in 
Nanog overexpressing embryos the expression pattern does not change. C) Sox3 expression in 
controls overlaps with that of Sox2, and is similarly unaffected in Nanog overexpressing 
embryos. 
Nanog overexpression also had no effect on Cdx2 expression. It might have been 
predicted than Nanog overexpression would downregulate Cdx2, in analogy with 
results from mouse ES cells (Chen et al., 2009). However, Cdx2 expression was 
unaltered, even when we carefully electroporated the embryo’s caudal part, where 
Cdx2 is normally expressed (Marom et al., 1997) (Fig. 20A).  
Interestingly, when we examined Eomes, not only was this factor not repressed by 
Nanog; its expression was upregulated (Fig. 20B). Although surprising, this result is in 
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line with a recent report from our group showing that Eomes is expressed in chick 
embryos in a novel domain not conserved with mouse, the PGCs (Pernaute et al., 
2010). Since Nanog is also expressed in PGCs (Canon et al., 2006) the interrelationship 
between these two genes must have changed since the separation of birds and 
mammals. 
 
Figure 20. Nanog overexpression does not change Cdx2 expression but upregulates Eomes. 
(A) Cdx2 is expressed in the caudal part of the primitive streak and its expression is unaltered 
by Nanog overexpression (B) In control embryos, Eomes expression is detected in the PGCs. 
Eomes expression is strongly upregulated by Nanog overexpression in the area of 
electroporation.  
A possible explanation to the previous results is that Nanog drives a general 
reprogramming, changing epiblast fate towards PGCs. If so, overexpression of Nanog 
would lead to a general upregulation of PGC markers such as Pou2-r and Eomes. We 
therefore examined the effect of Nanog overexpression on Vasa, one of the earliest 
and most specific germ cell markers across vertebrates (Tsunekawa et al., 2000). We 
did not find any change in Vasa expression, ruling out an overall reprogramming of 
Nanog overexpressing epiblast cells to a PGC fate (Fig. 21). 
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Figure 21. Nanog overexpression 
does not change Vasa expression. 
Immunohistochemistry with Vasa 
antibody stains only PGCs in both 
control and Nanog overexpressing 
embryos, as revealed by examining 
sections of Nanog overexpressing 
embryos, in which the PGCs are 
brighter and clearly visible above 
background. 
 
 
 
 
 
 
 
2.2.2 Nanog overexpression in the mouse embryo  
We overexpressed Nanog in the mouse embryo by using a doxycycline-dependent 
expression system (Hochedlinger et al., 2005). Overexpression of Nanog was induced 
by giving doxycycline to pregnant females during three days immediately before 
embryo extraction at E9.5, a stage equivalent to that studied in chick (HH10). Before 
analysing other core factors and TE markers, we confirmed Nanog overexpression by 
comparing embryos positive for both transgenic alleles (Tg.TetOP-Nanog and 
ROSA26::rtTA) with embryos that did not have both alleles. We refer to these embryos 
as Nanog and controls respectively. A robust expression of Nanog was obtained 
throughout Nanog embryos (Fig. 22A, B). 
Nanog overexpression did not upregulate Oct4 or Sox2 to levels detectable by in situ 
hybridization (Fig 22). Their expression patterns (Avilion et al., 2003; Scholer et al., 
1990) were maintained in Nanog overexpressing embryos (Nanog). 
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Figure 22. Nanog overexpresion does not change Oct4 or Sox2 expression in the mouse 
embryo. (A, B) In Nanog embryos Nanog is ectopically expressed (B) Arrowheads mark the 
location of the mid-hindbrain constriction (C, D) Oct4 expression is not upregulated in Nanog 
embryos (D). (E, F) In control embryos, Sox2 is detected throughout the brain, neural tube, 
sensory placodes, branchial arches and gut endoderm (E), a pattern unaltered in Nanog 
embryos (F).  
Expression of the TE marker Cdx2 in the posterior axial expression domain (Beck et al., 
1995) was not downregulated in Nanog overexpressing embryos (Fig. 23 A, B).  
Eomes expression is detected in the anterior neural domain in control embryos as 
described (Ciruna and Rossant, 1999) (Fig. 23 C, E), while it appears to be disrupted in 
the Nanog overexpressing embryos (Fig. 23 D, F). 
Closer examination of these embryos revealed they had a reproducible cranio-facial 
phenotype with a variety of morphological defects, among the most apparent being a 
lack of constriction between the midbrain and hindbrain (Figure 22 A, B). 
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Figure 23. Nanog overexpression does not change Cdx2 expression but alters Eomes (A, B ) In 
control embryos (A) Cdx2 expression is detected in the caudal pole, the posterior neural tube 
and the posterior gut endoderm, an expression pattern also found in Nanog embryos (B). (C-F) 
In the control embryos (C, D) Eomes expression is strong in the forebrain, where it is detected 
in the superficial layer of the telencephalic vesicles (arrows), and is excluded from the dorsal 
midline (asterisk). In Nanog embryos, expression is also found in the telencephalic vesicles but 
the pattern appears to be disrupted by the morphological defects. 
This observation led us to examine Fgf8, a key organizer in the development of the 
anterior nervous system, which is expressed in this constriction (called isthmus) (Sato 
and Joyner, 2009). Although Fgf8 is also expressed in the pharyngeal arch, developing 
limbs and tail bud (Crossley et al., 1996), in Nanog overexpressing embryos we found 
that the expression was altered exclusively in the area where the constriction normally 
develops. The expression was diffuse and extended anteriorly (Fig. 24 B, D), while in 
control embryos  Fgf8 expression was restricted to a sharp band marking the isthmus 
(Fig. 24 A, C). 
We wondered if Fgf8 expression might also be affected in chick. To test this we 
examined Nanog overexpressing chick embryos for expression of Fgf8. The chick 
orthologue is expressed in territories equivalent to those in mouse (Crossley et al., 
1996). Fgf8 expression was altered in the anterior region and might also be disrupted 
in the tail bud (Fig. 25). 
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Figure 24. Fgf8 expression pattern is 
disrupted by Nanog overexpression in 
mouse embryos. (A, C) In control embryos 
Fgf8 expression is found in the 
prospective forebrain (1), the midbrain-
hindbrain junction—in a constriction 
called the isthmus (2), the pharyngeal 
arches (3), developing limbs (4) and tail 
bud (5). In Nanog embryos (B, D) the sharp 
band of Fgf8 expression in the isthmus 
disappears, but the other expression 
domains are not affected. 
 
 
 
 
 
Figure 25. Fgf8 expression pattern is 
disrupted by Nanog overexpression in 
chick embryos. In control embryos Fgf8 is 
detected in cells surrounding the anterior 
neuropore in the forebrain (1); 
neuroepithelial cells in the isthmus (2); the 
branquial arch region (3); and the tail bud 
(4). In Nanog overexpressing embryos, 
Fgf8 expression is disrupted in the 
anterior region, where embryos exhibit 
morphological defects, and also appears 
to be disrupted in the tail bud. D, dorsal 
view; V, ventral view. 
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2.2.3 Global gene expression analysis 
To extend our analysis we examined gene expression in Nanog overexpressing 
embryos (E9.5) by microarray. 476 genes were differentially expressed in the Nanog 
overexpressing embryos compared with controls (corrected P-value cut-off set at 
0.05). Of these genes, 292 were downregulated and 184 were upregulated.  
Among the altered genes we distinguished two clear groups: one set of genes involved 
in nervous system development and function (87 genes) (Fig. 26), in line with our 
previous results showing morphological defects in the developing nervous system; and 
a second set of genes involved in haematological development (79 genes) (Fig. 27). 
Within both sets, most genes were downregulated. 
The set of downregulated genes associated with nervous system development 
included Otx2 and Sox2 (corrected P-value 0.02638322 and 0.01125896 respectively). 
Interestingly, one of the upregulated genes in this set was Fgf8 (corrected P-value 
0.047891). Otx2 function is related to Fgf8, since it is involved in the correct 
positioning of the mid-hindbrain constriction, limiting Fgf8 expression anteriorly (Li 
and Joyner, 2001). Fgf8 might be directly upregulated by Nanog and in turn repress 
Otx2, a relationship already demonstrated by (Liu et al., 1999). Another possibility is 
that Nanog directly represses Otx2, expanding Fgf8 expression into the dorsal 
midbrain, as occurs in Otx2+/- mice (Martinez-Barbera et al., 2001). 
Published evidence would predict that Sox2 expression would be upregulated (Boyer 
et al., 2005). Instead, we observed no change by in situ but a repression in the 
microarray. This repression might be a consequence of the neural tube defects in 
Nanog overexpressing embryos, since Sox2 has functions in nervous development 
(Miyagi et al., 2008) 
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    Arx                 Fezf1               Hes5                    Lhx2   Nkx2-1  Pou3f1  
    Ascl1   Fezf2               Heyl               Lhx5  Nkx2-2  Pou3f3  
    Barhl1              Fgf15                 Id4  Lmo3  Nkx2-4  Scube2  
    Dbx2       Foxg1               Irx1  Lmx1a  Nkx6-2  Six6     
    Dlx4   Fzd2  Irx2  Neurod4 Otx2  Sox2 
    Dmbx1  Hes2                   Lfng  Neurog2 Pax6  Wnt7b  
                                                                                                                      Wnt8b 
                           
 
Figure 26. List of representative genes involved in nervous system development and function 
downregulated by Nanog.  The genes were associated with their function in developing 
nervous system by using Mouse genome informatics (www.informatics.jax.org) and Ingenuity® 
Systems analysis (www.ingenuity.com).  
In the set of genes related to haematological system development, we identified 
certain genes, like Gata1 and Klf1, which have central roles in erythroid differentiation 
(Fig. 27) (Tallack et al.). 
A first examination did not associate upregulated genes with specific functional 
categories. However, in addition to Fgf8, two pluripotency genes were presented: 
FoxD3, which acts downstream of Oct4, Sox2 and Nanog; and Oct4 itself, although with 
a corrected P-value just below the cut-off (0.055125). Nanog overexpression might not 
upregulate significantly Oct4 because this gene has a negative feedback loop to 
regulate its own quantity at a rigid concentration (Pan et al., 2006) necessary to 
prevent ES cells differentiation (Niwa et al., 2000). 
Since we cannot distinguish between Nanog direct and indirect target, we mapped the 
vicinities of differentially expressed genes for the presence of Nanog binding sites 
characterized in ChIPseq analysis in ES cells (Chen et al., 2008; Marson et al., 2008). 
We found Nanog binding sites in Sox2 and Oct4, as expected (Boyer et al., 2005; Wang 
et al., 2006), but also found sites in other differentially expressed genes, including Fgf8 
(a binding site not conserved in chick), Otx2, Pax6, Dbx2, Lhx2 and Ascl1. 
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Target responsiveness to Nanog overexpression differs between chick and mouse 
embryos. The subnetwork downstream of Nanog might have changed during 
evolution, with new regulatory interactions appearing in the mammalian lineage, 
such as Oct4 autoregulation or Eomes repression by Nanog. Neural and 
haematopoietic alterations observed in Nanog overexpressing embryos suggest this 
gene, in addition to its pluripotency function, acts as a repressor of differentiation in 
embryonic development. 
 
Figure 27. Hematological system development network. Genes are represented as nodes, and 
the biological relationship between two nodes is represented as an edge (line). Lines represent 
direct interactions and dotted lines indicate indirect interactions. The intensity of the node 
color indicates the degree of up- (red) or down-(green) regulation and is proportional to the 
fold difference in gene expression. Numbers underlying each molecule indicate the fold change 
logarithm (logFC). Nodes are displayed using various shapes that represent the functional class 
of the gene product. (Ingenuity® Systems, www.ingenuity.com). 
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Pluripotency is the ability of a cell to generate all the cell types of an adult organism, a 
feature shared by early embryonic cells in the developing embryo and ES cells. 
Pluripotency is controlled in mammals by the action of a network of genes whose core 
factors are Oct4, Sox2 and Nanog. Despite significant advances in the field, little is 
known about the evolutionary history of this gene network and if it plays similar roles 
in non-mammalian vertebrates.  
A recent study argues for conservation of pluripotency and its genetic control in non-
mammalian vertebrates (Dixon et al., 2010). These authors described a homologue of 
the core network in axolotl and how it functions in mouse ES cells. They suggest, 
similarly to previous studies in chick and Xenopus (Lavial et al., 2007 ; Morrison and 
Brickman, 2006), that pluripotency factors are functionally equivalent among 
vertebrates. Our experiments confirm that opossum and chick Nanog are also able to 
functionally replace mouse Nanog in ES cells. Together, these experiments show that 
the homologues of the core factors are able to bind to mouse EP targets in ES cells, 
suggesting the core factor binding specificities might be conserved between mouse 
and other vertebrates. However, this does not necessarily imply conservation of the 
pluripotent state in these organisms, since the function and networking of these 
factors in vivo might differ. 
Recent comparative genome-wide studies between different mammalian species in 
fact point to a high degree of plasticity of the EP-GRN (Kunarso et al., 2010; Xie et al., 
2010). The EP-GRNs of mammals share core components indispensable for 
pluripotency, and the variability is located mainly in the peripheral components. The 
authors described that these components underwent substantial alterations through 
single nucleotide mutations, leading to turnover of transcription binding sites and 
insertion of cis-regulatory modules partly mediated by transposons. The outcome of 
these changes was a rewiring of the EP-GRNs in mammals. 
Our results comparing mouse and chick provide further insights into the evolution of 
embryonic pluripotency and suggest that the EP-GRN is a mammalian novelty.  The EP-
GRN arose not only from the appearance of new pluripotency genes but also by co-
opting and duplicating existing ones and by establishing new regulatory inputs 
between them. We found that some EP-GRN genes are specific to mammals but that  
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the core pluripotency factors were already present in avians and other vertebrates, 
even though they might have different roles to their homologues in the mouse 
embryo. Furthermore, the way the pluripotency factors are connected in the EP-GRN 
appeared in mammals, and the network subsequently underwent further rewiring 
(Kunarso et al., 2010; Xie et al., 2010).  
Our results from Nanog overexpression in chick and mouse embryos also suggest that 
many pre-existing genes have been rewired into the mammalian EP-GRN by the 
appearance of new regulatory interactions. This is supported by a study comparing 
zebrafish and mouse Pou5 transcriptional networks, which suggests that Pou5 
subnetworks were co-opted in mammals for additional novel functions based on new 
interacting partners or feedback loops (Onichtchouk et al.).  For example, the Oct4 
autoregulatory mechanism characteristic of mammals is not present in zebrafish 
(Onichtchouk et al.) or in chick, as suggested by our results from Nanog 
overexpression. We also found that in the mammalian lineage Nanog became a 
repressor of Eomes (Fig 1). 
Since our conclusions stem mainly from comparison with mouse, a potential concern 
might be the degree of conservation of the EP-GRN among mammals. The most 
detailed comparisons among mammals carried out so far have been between mouse 
and human ES cells. These studies show that the core factors (Boyer et al., 2005) and 
many other EP-GRN genes (Kim et al., 2005; Kuntz et al., 2008; Monk et al., 2008) are 
conserved in both mammalian species. However, striking differences have been found 
between human and mouse ES cells in their morphology and culture requirements 
(Pera and Trounson, 2004), targets of EP-GRN core factors (Boyer et al., 2005; Loh et 
al., 2006), and critical signalling networks and gene expression profiles (Ginis et al., 
2004).  These differences might indicate that mouse and human ES cells are not 
equivalent embryonic cell populations, and therefore are not directly comparable. 
Indeed, human ES cells share more characteristics with mouse epiblast-derived stem 
cells (EpiS) than with mouse ES cells (Brons et al., 2007; Tesar et al., 2007). Therefore, 
human ES cells might not be equivalent to mouse ES cells but to mouse EpiS cells. 
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1. Early patterning in the chick embryo 
We examined the pre-gastrulation chick embryo for the expression of homologues of 
important mouse EP-GRN genes.  The core pluripotency factors are present across 
amniotes but their expression patterns in the early chick embryo are different from 
those found in mouse. Chick Nanog is expressed only in primordial germ cells of the 
pregastrulation chick embryo (Canon et al., 2006); the putative chick Oct4 homologue 
ubiquitously expressed in the epiblast at stage EGK-XI (Fig. 1) (Lavial et al., 2007) is not 
a true orthologue of mouse Oct4, but a paralogue.  Our analysis shows that avians lack 
a true Oct4 orthologue. In fact the complex duplicative history of Oct4 that we found in 
vertebrates has been confirmed by the presence of Pou2-r and fully functional Oct4-r 
genes in a monotreme, the platypus, (Niwa et al., 2008) and in a marsupial, the 
tammar wallaby (Frankenberg et al., 2010). Niwa et al. suggest that the Oct4 gene 
found today in eutherian mammals is the result of a duplication event which occurred 
during early mammalian divergence. Furthermore these authors propose a causal 
relationship between the duplication and the appearance of a new function of Oct4 in 
the early mammalian embryo: the reciprocal inhibition of Oct4 and Cdx2. However, our 
finding that the Oct4 genomic region may have been specifically lost in avians, 
together with our identification of an Oct4 orthologue in the lizard genome, date the 
duplication of the Oct4-related genes before the divergence of avians and mammals, 
as recently suggested by (Frankenberg et al., 2010). These findings refute any 
relationship between the duplication event and the acquisition of the new interaction 
between Oct4 and Cdx2. 
In addition we found that other transcription factors such as Sox2 and FoxD3 and the 
signalling molecules Fgf4 and Nodal are not expressed until post-gastrulation stages, in 
contrast to their mouse orthologues which are expressed in the blastocyst ICM and 
epiblast (Fig. 1) (Avilion et al., 2003; Hanna et al., 2002; Niswander and Martin, 1992; 
Takaoka et al., 2006). 
It could be argued that, in some cases, paralogues might be redundant. This could be 
the case for Sox1 and Sox3, paralogues of Sox2. However, Sox1 is not expressed in the 
epiblast, and Sox3 is not expressed in the whole epiblast (Wilson et al., 2001) and the 
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significance of its epiblast expression is difficult to judge. First, Sox3 is not able to fully 
replace Sox2 in the generation of iPS cells (Nakagawa et al., 2008); and second, Sox3 is 
not expressed in the early mouse embryo until post-implantation stages 
(www.informatics.jax.org). Therefore, if Sox3 were the partner of Pou2-r in chick, this 
would imply that the mammalian lineage had lost early Sox3 expression concomitantly 
with the gain of pluripotent expression of Sox2. Thus, even in the case of an exchange 
of function between Sox2 and Sox3, this would have involved dramatic changes in the 
regulation and function of these genes and the network between avians and 
mammals. 
We did not examine the expression of all these genes at earlier stages of embryonic 
development inside the chick oviduct, when they might exert a role in embryonic 
pluripotency and lineage specification. However, such a role is unlikely, since at these 
stages the zygotic genome has still not activated, and these genes could therefore only 
be expressed maternally: For these genes to exert their differential functions, there 
would have to be mechanisms for asymmetrically distributing maternal transcripts 
between the different territories of the embryo or for permitting their translation only 
in specific regions. It is true that maternal expression of the zebrafish Pou5f1-related 
gene pou2 is required for early endodermal development (Reim and Brand, 2006), and 
mouse Oct4 is expressed maternally in the oocyte (Ovitt and Scholer, 1998). However, 
the role in pluripotency of mouse Oct4 is related to its zygotic expression, and the 
restricted expression of Oct4 in the blastocyst is under the control of regulatory 
elements that are activated zygotically and not in the oocyte (Yeom et al., 1996). 
Therefore, a role for maternal expression of these genes in pluripotency in the chick 
would imply a switch from maternal to zygotic control in the evolution of mammals, 
which is highly unlikely.  
Taken together, the comparative expression analysis between pre-gastrulation mouse 
and chick embryos suggests that the EP-GRN was newly assembled in mammals, where 
expression of core transcription factors appeared in novel domains in space and time 
during evolution. Moreover microarray analysis complements and confirms the 
conclusions drawn from the in situ analysis, demonstrating that the pre-gastrulation 
chick embryo does not show a general enrichment in the expression of orthologues of 
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mouse pluripotency-related genes. This again suggests that the EP-GRN is not 
deployed in the same manner in the early mouse and chick embryo. 
In line with the results presented here, recent work from our group has found 
differences in the expression patterns between chick and mouse for genes involved in 
the GRN that controls extraembryonic fate (Pernaute et al., 2010). Although in the 
early chick embryo Cdx2 and Eomes are expressed in extraembryonic tissues (area 
opaca), both differ from mouse in their time of expression, making it unlikely that the 
action of Cdx2 upstream of Eomes seen in mouse also occurs in chick. In addition, 
unlike mouse, Eomes is expressed in the PGCs. This indicates that chick Nanog and 
Pou2-r cannot repress Eomes as occurs in mouse. What is more, orthologues of Bmp4 
and Fgfr2, which in mouse are expressed in TE and extraembryonic ectoderm, are not 
expressed in the early chick extraembryonic domains (Fig. 1). These findings suggest 
that not only was the EP-GRN newly assembled in mammalian evolution, but also that 
the appearance of the trophoectoderm was accompanied by critical changes in the 
GRN controlling the extraembryonic lineage. 
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Figure 1. Diagram showing the differences between chick and mouse genes involved in 
embryonic pluripotency and specification of extraembryonic and PGC fates. During 
mammalian evolution, some genes whose orthologues were already present gained new 
expression domains and established new regulatory interactions. (A) Diagram of a EGK-X chick 
embryo, with the area opaca (outer circle, green), the area pellucida (inner circle, light orange) 
and PGCs scattered over the latter (small orange circles). While Cdx2 and Eomes are expressed 
in the extraembryonic domain (area opaca), Pou2-r is expressed in the embryonic domain 
(area pellucida). This gene, together with Eomes and Nanog, is expressed in the PGCs. (B) 
Diagram of a cross-section through the mouse blastocyst perpendicular to the embryonic-
abembryonic axis. While Cdx2 and Eomes expression is conserved in the extraembryonic 
domain (green), two genes, Bmp4 and Fgfr2, changed their expression in time and space and 
are now expressed in this domain. Nanog changed its spatial expression and is no longer 
restricted to the PGCs but is expressed in the whole embryonic domain (light orange). The 
paralogue of Pou2-r, Oct4, is also expressed in the embryonic domain together with Sox2, 
Nodal, Fgf4 and FoxD3, which changed their expression in time and space. While Oct4 is found 
in PGCs in analogy with its Pou2-r paralogue, Nanog expression is conserved and Eomes 
expression is lost. Genes in grey are not expressed in the chick embryo at this stage, black lines 
indicate evidence for interaction; grey lines indicate no evidence. 
 
2. Recruiting genes to the EP-GRN 
Genomic analysis shows that some EP-GRN genes are specific to mammals and in many 
instances arose by gene duplication, such as Gdf3 (Canon et al., 2006) and Rex1 (Kim et 
al., 2007). Gene duplication events generally provide a chance to evolve new gene 
functions, for example via the establishment of new protein-protein interactions 
(Wagner and Lynch, 2005) as suggested in the case of Oct4 (Niwa et al., 2008). 
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Therefore, it is tempting to speculate that gene duplications were major events behind 
the emergence of the pluripotency regulatory network. However, targets of core 
pluripotency factors (Marson et al., 2008) are not enriched in mammalian specific 
genes. Furthermore, we found that the duplication of Oct4 occurred before the 
divergence of amniotes, indicating that all core pluripotency factors were present long 
before the appearance of mammals. Therefore, if the EP-GRN was newly assembled in 
mammals, as the expression data suggest, it must have occurred not only by the 
appearance of novel genes but also through the recruitment of pre-existing ones (Fig. 
2).  
 
 
Figure 2. How the EP-GRN was built. EP-GRN arose by co-option (Nanog, Sox2, Fgf4), 
duplication (Pou2-r) and the appearance of novel genes (Dppas, Utf1), as well as new 
regulatory interactions that recruited new direct targets of the core factors or established 
reciprocal inhibition loops between the embryonic pluripotency core factors (Nanog, Oct4 and 
Sox2) and extraembryonic specifiers (Cdx2, Eomes). 
The most obvious way in which genes can gain new expression domains is through the 
appearance of novel cis-regulatory elements in their vicinity, allowing novel regulatory 
links (Wagner and Lynch, 2005). We find that the genomic regions bound by the core 
EP-GRN factors show very little conservation between mouse and chick, in accordance 
with them being new elements in the mammalian lineage. Further evidence for this 
comes from the fact that these regions are enriched in rodent- and mouse-specific 
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sequences, reflecting their recent evolutionary appearance. In contrast, rodent- and 
mouse-specific sequences are not found in the Gli3-bound regions of the more ancient 
limb-specification GRN (Vokes et al., 2008). Within the mammalian lineage, the lower 
degree of conservation we found in regions bound by Oct4 and Nanog compared with 
the GRN controlling limb development (Results Fig. 11A) is in agreement with recent 
findings on the re-wiring of peripheral components of the EP-GRN (Kunarso et al., 
2010; Xie et al., 2010).  
A more informative analysis of genes targeted by Oct4 and Nanog could in principle be 
made by comparing genome-wide binding profiles for these genes in chick and mouse, 
such analysis would be extremely informative regarding the evolution of the network. 
However, this approach is currently not possible, because the antibodies to the mouse 
proteins do not cross-react with their chick homologues, precluding their use in chick 
ChIP-sequence approaches. 
Our prediction that novel elements regulated by core pluripotency factors first 
appeared in mammals were confirmed by two examples. The sequences surrounding 
the Sox2/Oct4 cassette, which are critical for the expression of Fgf4 and Sox2 in the 
pre-implantation embryo and ES cells (Fraidenraich et al., 1998; Tomioka et al., 2002; 
Yuan et al., 1995), are sufficiently conserved between mammals and chick to allow us 
to identify critical nucleotide changes that resulted in the appearance of adjacent 
functional HMG and POU binding sites. Functional assays in ES cells and pre-
implantation embryos with the mouse enhancers and the corresponding chick genomic 
fragments, together with mutated versions where the sites were swapped between 
mouse and chick, show that the Sox2/Oct4 cassette is necessary but not sufficient for 
activity in pluripotent cells. This indicates that the mouse EP enhancers contain other 
non-conserved sequences necessary for activity that remain to be identified. Our 
results also demonstrate that the chick sequences, although similar enough to the 
mouse to identify the nucleotides corresponding to the Oct4/Sox2 cassette, do not 
respond to endogenous Oct4 or Sox2. An obvious interpretation is that the nucleotide 
differences we observe in the chick correlate with changes in the binding specificities 
of the factors. Therefore, we investigated the potential of both mouse Oct4 and chick 
Pou2-r, which show divergent protein sequences, to bind to pluripotency enhancers.
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 The results show that the proteins per se are largely interchangeable and are capable 
of acting equally on the mouse Oct4 distal enhancer. This assay extends previous 
findings (Lavial et al., 2007) that showed that Pou2-r was able to substitute the 
endogenous Oct4 in mouse ES cells and activate the proximal Oct4 promoter. 
However, the promoter used by these authors, while active in EpiS cells and in the 
epiblast, is not pluripotency-specific.  
Our results suggest that the major changes that have occurred during evolution are 
mainly due to changes in the wiring of the network, and not to changes in the binding 
specificities of the factors. To further test this we also examined the ability of Oct4 and 
Pou2-r to activate the Fgf4 and Sox2 pluripotency enhancers, obtaining similar results 
to those for the Oct4-distal enhancer. More interestingly, we also found that chick 
Pou2-r cannot bind to the chick genomic regions homologous to these enhancers, and 
neither the mouse enhancers where the critical residues in the binding site for Oct4 
have been mutated to those present in the chick. This set of experiments therefore 
demonstrates that the changes in the mouse genome do not simply represent a 
change in binding site preference of the core factors.   
3. What is special about embryonic pluripotency in mammals? 
Our results raise the question of why a new gene regulatory network responsible for 
maintaining embryonic pluripotency should have arisen in mammals. We believe the 
answer may lie in the peculiar nourishment requirements of early mammalian 
embryos. In the embryos of most vertebrates (and invertebrates), the egg is supplied 
with yolk that feeds the embryo throughout development. This kind of embryo grows 
by a series of quick cell divisions (O'Farrell et al., 2004), and patterning is initiated 
shortly after fertilization by maternal and/or external factors (such as the sperm entry 
point in amphibians, or gravitation in the chick).  The situation is radically different in 
mammals, where eggs are devoid of yolk and embryo nourishment must be obtained 
through direct contact with the maternal uterine wall via the placenta. This change has 
been accompanied by the loss of genes encoding vitellogenin proteins, stored in the 
yolk of other species as a nutritional reservoir (Brawand et al., 2008), and the 
appearance of a new cellular population, the trophoblast, which gives rise to the 
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majority of the placenta. In this regard, we also found striking differences in the 
expression of orthologues of extraembryonic genes in the early chick embryo 
(Pernaute et al., 2010). Initial cell divisions of the mammalian embryo, as observed in 
mouse, are extremely slow (O'Farrell et al., 2004), and until implantation there is 
hardly any growth. Recent evidence indicates that embryonic patterning in mammals is 
not initiated until peri-implantation stages, long after fertilization (Rossant and Tam, 
2009). In fact, the first differentiation event to occur is the specification of the 
trophectoderm lineage, which is unique to mammals. Another key characteristic of the 
mouse embryo is that patterning is initiated by intrinsic and zygotic mechanisms: no 
external trigger or maternal signal is needed to establish the mayor body axes. This is 
most clearly illustrated in tetraploid aggregation chimeras, where nearly the whole 
embryo is derived from ES cells, which do not retain any spatial patterning information 
after prolonged growth and passage in tissues (Eakin and Hadjantonakis, 2006).  
Therefore in mammalian embryos the delay in pattern formation and the uncoupling 
from external cues necessitate prolonged maintenance of embryonic cells in an 
undetermined and quiescent state (Fig. 3). The evolutionary appearance of the EP-GRN 
would have permitted this state, with the core factors (Oct4-Sox2-Nanog) silencing 
genes involved in early differentiation and specification (Boyer et al., 2005; Loh et al., 
2006) while leaving them ready to be expressed in a controlled spatial and temporal 
fashion. Epigenetic modifiers might contribute to the dual situation of those genes. 
Recent studies have shown that a subset of developmental genes is modified by so-
called bivalent domains. These domains are a combination of activating and repressive 
histone modifications, therefore contributing to silencing developmental genes while 
keeping them poised for activation (Bernstein et al., 2006). 
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Figure 3. Differences between non-
mammalian and mammalian early 
development. In non-mammals early 
patterning is driven by asymmetrically 
distributed maternal determinants or 
external cues; in mammals, in contrast, 
patterning is driven by zygotic transcription. 
This loss of dependence on maternal or 
external cues considerably delayed the 
onset of patterning in mammals. Therefore, 
mammalian embryos needed an extended 
period in which embryonic cells were 
maintained in a pluripotent state before 
differentiation. 
  
Some light on the origin of the EP-GRN is shed by the fact that Nanog and Oct4 
homologues of both mouse and chick embryos are expressed in PGCs (Canon et al., 
2006; Lavial et al., 2007). PGCs resemble ES cells in many respects (Seydoux and Braun, 
2006; Zwaka and Thomson, 2005), and a possible scenario would be that Nanog and 
Pou5 genes act in PGC to prevent their differentiation and maintain their germline 
potential until differentiation of the mature germ cells. The requirement for both 
factors in mouse germ cell development has been shown (Chambers et al., 2007; 
Kehler et al., 2004; Okamura et al., 2008; Yamaguchi et al., 2009) and pluripotency 
maintenance in PGCs may therefore be an older, evolutionarily conserved role for 
these genes in vertebrates that was later co-opted and expanded to form the network 
responsible for the same function in early embryonic cells of mammals. 
Our results also have implications regarding the nature of chick ES cells, which might 
originate from PGCs in the early chick embryo. Chick ES cells have been derived from 
EGK-X blastoderm cells and maintained in an undifferentiated state in culture. These 
cells can contribute to somatic tissues in chimaeras (Petitte et al., 2004) but they do 
not contribute (van de Lavoir et al., 2006b) or only very poorly (Carsience et al., 1993; 
Pain et al., 1996) to the germ line. Another difference with mouse ES cells is that  
undifferentiated growth of chick cells requires Fgf in the culture medium (Lavial et al., 
2007), while this growth factor promotes differentiation of mouse ES cells (Silva and 
Smith, 2008). Cytokines and culture conditions for chick ES cells are highly similar to 
those used to amplify chick embryonic germ (EG) cells from gonadal cells or culture 
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PGCs in vitro (Lavial and Pain, 2009). Moreover, chick ES cells express low levels of the 
Vasa homologue Cvh (Lavial et al., 2009), some germinal-associated genes and the 
chick homologue of Eomes (Lavial and Pain, 2009), whose expression is clear in chick 
PGCs (Pernaute et al., 2010) but is absent in mouse ES cells. 
These marked differences with mouse ES cells might be explained if chick blastoderm-
derived pluripotent cells are derived from PGCs present in the freshly dissociated 
epiblast. Some of the few PGCs might gain a proliferative advantage and maintain an 
undifferentiated state as a result of the culture conditions, coming to resemble an EG 
cell type (van de Lavoir et al., 2006a). Therefore, mouse ES cells and chick blastoderm-
derived pluripotent cells might have a different embryonic origin. Our hypothesis 
questions the possibility of reprogramming somatic cells in avian species. 
4. Nanog in early differentiation of neural and haematopoietic precursors  
Nanog overexpression causes neural defects in mouse and chick embryos. Our results 
show altered expression levels of genes involved in neural differentiation, such as Fgf8 
and Otx2. Similarly to our Nanog overexpressing embryos, null mutants for either of 
these genes present defects in rostral brain development. Interestingly Fgf8 and Otx2 
are among the earliest genes to be expressed in the epiblast and they are required for 
proper gastrulation (Ang et al., 1996; Sun et al., 1999). Given that Nanog transcripts 
are still expressed in the epiblast until early streak stages (E6.5), Fgf8 and Otx2 could 
be Nanog targets in the early epiblast. This is supported by the fact that Nanog binding 
sites were found by ChIP in the vicinity of both genes (Chen et al., 2008; Marson et al., 
2008). Therefore Nanog might repress Fgf8 and Otx2 at early gastrulation, and the 
Nanog overexpression we induce at later stages would recapitulate the regulatory 
interactions that occur in the early epiblast. 
We found that Fgf8 expression was exclusively altered in the isthmus. One possibility is 
that the developmental state or history of this territory confers on it a different 
potential to respond to the Fgf8 inductive signal, a competence other Fgf8 expression 
domains do not have. Interestingly, mutants for zebrafish pou2/spg, which is 
expressed in the neural plate, are characterized by absence of the isthmus, altered 
Fgf8 expression in this region, and changes in forebrain markers (Reim and Brand, 
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2002). This is very similar to what we observed in Nanog overexpressing embryos. The 
authors demonstrate that the competence to respond to Fgf8 signalling during the 
establishment and maintenance of the mid-hindbrain is mediated by pou2/spg, a 
function which might be conserved in other vertebrates. In chick, functional 
conservation might be indicated by the strong expression of Pou2-r in the mid-
hindbrain from HH8 (Lavial et al., 2007).  However, Oct4 is not expressed in the neural 
plate in mouse. 
Chick Nanog is also expressed in the anterior neural plate from HH6 (Lavial et al., 
2007). However, Nanog is not expressed either in the neural plate in mouse. 
Therefore, in mammals, even though Nanog’s regulatory inputs into neural 
differentiation might be conserved–as suggested by Nanog overexpression results, its 
neural expression is lost. 
Mouse embryos overexpressing Nanog also present alterations in genes related to 
haematological development. Similar to the situation with neural genes, Nanog might 
repress those genes involved in haematopoietic differentiation at the gastrulation 
stage.  
Therefore, Nanog, in addition to controlling pluripotency, might be important at 
gastrulation stages, repressing genes involved in the differentiation of certain 
precursors. Further analysis must be conducted to confirm this function and study its 
conservation during evolution. 
Our research has extended our understanding of mammalian embryonic pluripotency, 
providing a more complete picture of its control and evolution, which is an important 
step in this exciting era of the regenerative medicine. 
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1. The EP-GRN was newly assembled in mammals. Orthologues of many genes involved 
in embryonic pluripotency and early lineages in mouse are not expressed in equivalent 
territories of the early chick embryo. These chick embryos and their derived cells in 
culture differ in their global expression profiles from the mouse pluripotent state. 
2. The EP-GRN was partly assembled through the appearance of new pluripotent genes 
that in many instances arose by duplication. However, such events were not the main 
driver of the emergence of the EP-GRN. First, all core pluripotency factors were 
present long before the appearance of mammals. Second, downstream targets of the 
mouse core pluripotency factors are not enriched in mammalian specific genes. 
3. The EP-GRN was mainly assembled by co-opting pre-existing genes through the 
appearance of core EP factor response elements. The genomic sequence elements 
which mediate the downstream action of the mouse core pluripotency factors are non-
conserved with chick.   
4. The major changes in the appearance of the EP-GRN were in the wiring of the 
network. The new wiring by novel response elements allowed the core factors to gain 
new expression domains and/or regulatory interactions. Interestingly these core 
factors did not change their binding specificities during the evolution.  
5. The novel regulatory elements appeared by modest changes such as single 
nucleotide mutations or insertions. These types of changes created novel Oct4/Sox2 
binding sites in the mouse Fgf4 and Sox2 pluripotency genes. The corresponding 
sequences in chick are unable to bind Oct4 and Sox2. 
6.  The EP-GRN might have arisen to support the peculiar nourishment requirements of 
early mammalian embryos, which necessitate prolonged maintenance of embryonic 
cells in an undetermined state before engaging in differentiation programs.  
7. Nanog might have conserved functions additional to controlling pluripotency, acting 
as a repressor of neural and haematopoietic differentiation at gastrulation stages. 
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1. El ensamblaje de la red génica que regula la pluripotencia embrionaria ocurrió en la 
evolución durante la aparición de los mamíferos. Hemos encontrado que los ortólogos 
de genes involucrados en la pluripotencia embrionaria y en los linajes tempranos de 
ratón, no se expresan en el embrión temprano de pollo en los territorios considerados 
equivalentes al embrión de ratón. Además, el perfil de expresión global del estadio 
pluripotente de ratón es muy diferente a los perfiles que encontramos en los 
embriones tempranos de pollo y a las células derivadas de éstos. 
2. La aparición de  nuevos genes de pluripotencia que en muchos casos surgieron por 
duplicaciones, fue importante para el ensamblaje de la red génica regulatoria de la 
pluripotencia embrionaria. Sin embargo estos eventos no fueron los grandes 
impulsores de la aparición de la red de pluripotencia embrionaria. Primero porque 
todos los factores centrales de la pluripotencia ya estaban presentes antes de la 
aparición de los mamíferos. Segundo porque hemos visto que en el ratón entre las 
dianas downstream a los factores centrales de pluripotencia no abundan los genes 
exclusivos de mamíferos. 
3. La red génica regulatoria de la pluripotencia embrionaria se ensambló 
principalmente cooptando genes ya existentes, mediante la aparición de elementos de 
respuesta a los factores centrales de la pluripotencia embrionaria. De hecho hemos 
encontrado que no están conservados en pollo los elementos de secuencia génomica  
que median la acción downstream a los factores centrales de pluripotencia en ratón. 
4. Los cambios que tuvieron lugar  en las conexiones fueron los que impulsaron la 
aparición de la red génica de la pluripotencia embrionaria. Las nuevas conexiones 
creadas por los nuevos elementos de respuesta permitieron a los factores centrales 
adquirir nuevos dominios de expresión y nuevas interacciones regulatorias. Sin 
embargo los factores centrales no cambiaron sus especificidades de unión a lo largo de 
la evolución.  
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5. Los nuevos elementos reguladores surgieron por pequeños cambios, tales como 
mutaciones de un solo nucleótido o inserciones.  Este tipo de cambios fueron 
probablemente los que crearon los nuevos sitios de unión para Oct4 y Sox2 en los 
genes de pluripotencia Fgf4 y Sox2. De hecho encontramos que en pollo las secuencias 
correspondientes a los sitios de unión son incapaces de unir los dos factores. 
6. La aparición en mamíferos de una red de regulación de la pluripotencia embrionaria 
quizá no sea casual sino relacionada con las peculiaridades y requerimientos 
nutricionales del embrión temprano de mamíferos. Éste necesitaba prolongar el 
mantenimiento de las células embrionarias en un estado indeterminado antes de 
embarcarse en procesos de diferenciación y la nueva red se lo habría permitido. 
7. Nanog podría, aparte de regular la pluripotencia, tener un papel adicional y 
conservado a lo largo de la evolución como represor de la diferenciación neural y 
hematopoyética en los estadios de gastrulación. 
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